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Abstract 
The activation of B cells culminates in a fate decision between plasma cell or memory B 
cell differentiation pathways. Mice lacking the Ets transcription factor Spi-B exhibit 
impaired secondary antibody (Ab)-forming responses. The role of the related factor Spi-C 
in Ab-forming responses remains unknown. Using Spib-/-Spic+/- mice, we showed that 
heterozygosity of Spi-C rescued reductions in secondary IgG1-secreting cell frequencies. 
Spib-/- and Spib-/-Spic+/- B cells generated increased frequencies of CD138+ cells, relative 
to WT B cells. Spib-/- B cells underwent accelerated differentiation compared to WT B 
cells, while Spib-/-Spic+/- B cells exhibited a lag in differentiation. Gene expression analysis 
indicated that Bach2 was downregulated in CD138+ Spib-/- cells. ChIP experiments 
suggested that Spi-B and Spi-C were enriched at Ets binding sites located within Bach2 in 
stimulated B cells. Our results point to a novel role for Spi-C in opposing the function of 
Spi-B in activated B cells. 
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1 Chapter 1: Introduction 
1.1 The B cell: A Look Inside the Immune Arsenal 
The immune system contributes to the establishment and dynamic maintenance of 
homeostasis throughout an organism’s life. Its physiological mandate is to protect the 
organism from infectious pathogens, to eliminate malignancies, to tolerate commensal 
bacteria, to recognize host tissues and to assist in their repair (Parham, 2015). In higher 
vertebrates, this complex balancing act is carried out via two complementary arms—known 
as innate and adaptive immunity. The innate arm constitutes a first line of defense against 
invading microorganisms, and is primarily required for early recognition and short-term 
control of infection. Innate immunity provides non-pathogen-specific protection in 
prokaryotic and eukaryotic species, likely borne out of a primal need for early unicellular 
organisms to accurately discriminate between ‘self’ and ‘non-self’ entities (Janeway, 
1992).  
Despite its complexity and well-honed coordination, the innate arm is intrinsically limited 
in its ability to resolve infections, due to its lack of specificity and inability to form 
‘memories’ of past pathogenic encounters. The second barrier to infectious or malignant 
non-self, the adaptive arm, is recruited by innate-derived inflammation. Adaptive 
immunity, unlike its innate counterpart, specializes in the generation of pathogen-specific 
responses, which are improved upon iterative exposures. The ability of adaptive responses 
to improve upon repeated encounters, in terms of both quality and rapidity, has been termed 
memory (Parham, 2015). 
The functions of the adaptive arm are primarily carried out by B and T lymphocytes. B 
cells collectively constitute a diverse population of immune cells, and are unique in their 
ability to give rise to antibody-forming cells. Antibodies are secreted effector proteins 
which display binding specificities to a near infinite array of pathogen-associated 
molecular conformations. Upon binding their target epitope, antibodies mediate the 
resolution of infections via neutralization, opsonization and complement activation, or by 
inducing antibody-dependent cell-mediated cytotoxicity (Diebolder et al., 2014; Tang et 
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al., 2007; Vidarsson, Dekkers, & Rispens, 2014). In addition to their ability to generate 
plasma cells, B cells can give rise to memory B cells—a population of long-lived, antigen-
specific cells poised to induce timely antibody-forming responses in the event of pathogen 
re-encounter (Kurosaki, Kometani, & Ise, 2015). Modern vaccines have long capitalized 
upon the ability of B cells to generate long-lasting protection against a wide range of 
infectious agents (Buisman, de Rond, Öztürk, ten Hulscher, & van Binnendijk, 2009). 
Current challenges to vaccine development, such as the generation of robust and lasting 
responses in elderly patients, highlight a pressing need to better understand B cell biology, 
and the interplay of factors which shape antibody-forming responses to immunization or 
natural infection. 
1.2 Murine B cell development 
B cell development is ongoing throughout life, and proceeds, in its earliest stages, from the 
commitment of pluripotent hematopoietic stem cells to the lymphoid fate within the bone 
marrow (BM) (Hardy, Kincade, & Dorshkind, 2007). Self-renewing, pluripotent CD34+ 
hematopoietic stem cells give rise to the three lineages that make up blood cells and 
platelets—namely the myeloid, erythroid and lymphoid lineages (Parham, 2015). 
Following its commitment to the lymphoid fate, and prior to its egress from the BM, a 
murine B cell precursor sequentially enters through five stages of development: the pre-
pro-B cell, pro-B cell, large and small pre-B cell, and finally immature B cell stages (Hardy 
et al., 2007). In 1991, an effort led by Hardy and colleagues resulted in the codification of 
murine B cell development (Hardy et al., 2007; Hardy, Carmack, Shinton, Kemp, & 
Hayakawa, 1991). The ensuing model relies on phenotypic and functional markers, along 
with immunoglobin heavy chain (IgH) and light chain (IgL) rearrangement status to 
identify developmental milestones in B cells (Hardy et al., 1991). Progression from one 
stage to the next is dependent upon successful rearrangements of immunoglobulin gene 
regions, which ultimately give rise to a collectively diverse B cell receptor (BCR) 
repertoire (Hardy et al., 2007, 1991). As progenitor B cells progress through these 
developmental stages, sequential rearrangement of Ig gene regions is initiated by the 
recombination-activating genes (RAG1/2) proteins, which are guided by recombination 
signal sequences (RSS) to generate double-stranded DNA breaks (Oettinger, Schatz, 
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Gorka, & Baltimore, 1990). Repair of RAG-generated DNA breaks relies on the process 
of non-homologous end-joining, allowing for the generation of a staggeringly diverse 
repertoire of BCR specificities (Herzog, Reth, & Jumaa, 2009; Yaari et al., 2015). 
Recombination of a limited number of Ig genes thus confers onto pools of 
immunocompetent B cells the ability to recognize an estimated 1014 antigens (Herzog et 
al., 2009; Yaari et al., 2015). 
1.2.1 Intramedullary development 
In the bone marrow, B220-expressing pre-pro-B cells and pro-B cells undergo 
rearrangement of heavy chain DH-JH regions, and VH-DHJH regions, respectively (Hardy et 
al., 1991). B220+CD43+CD24-AA4.1+ pre-pro-B cells (Hardy Fraction A) are somewhat 
unique amongst B cell progenitors in their ability to give rise to other lymphoid cell types, 
including NK cells, as they express low levels of the transcription factor Pax-5 (Rolink et 
al., 1996; Rolink, Nutt, Melchers, & Busslinger, 1999). Pax-5 promotes lineage 
commitment in B cells by rendering Ig loci accessible for VDJ recombination, as well as 
by inducing the expression of lineage-specific markers, such as CD19 (Busslinger, Nutt, 
Heavey, & Rolink, 1999; Kaneko et al., 1998). Progression from the earliest stages of B 
cell development relies on extrinsic cues provided by BM stromal cells. Perhaps most 
notably, interleukin (IL)-7 drives the survival and proliferation of pro-B cells in a STAT5-
mediated manner, and is critically involved in promoting the accessibility of VH and DH 
genes (Corcoran, Riddell, Krooshoop, & Venkitaraman, 1998; Malin et al., 2010).  
Following successful rearrangement of the Igµ locus, B220+CD43+CD24+ pro-B cells 
(Hardy Fraction B/C) transition to the large pre-B cell stage (Fraction C’), wherein these 
cells begin expressing assembled pre-BCRs on their surface (Hardy et al., 2007). 
Expression of the pre-BCR, consisting of the rearranged µ chain along with CD79a, CD79b 
and surrogate light chain (SLC) proteins, represents an important checkpoint in B cell 
development (Kitamura, Roes, Kühn, & Rajewsky, 1991). Concurrent signaling through 
the pre-BCR and IL-7R transiently drives proliferation throughout the large pre-B cell 
stage (Clark, Mandal, Ochiai, & Singh, 2014). This proliferative burst seems to be 
inherently self-limited, as the pre-BCR antagonizes IL-7 signaling, as well as its own 
constituents and downstream effectors (namely, SLC proteins, BLNK and SYK), as is 
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reviewed elsewhere (Clark et al., 2014). The differentiation pressure provided by the pre-
BCR subsequently allows the developing B cell to enter the resting state required to initiate 
IgL rearrangement (Rajewsky, 1996). The B220+CD43-CD24+ small pre-B cell (Fraction 
D) undergoes its transition to the immature B cell stage (Fraction E) after producing a 
successful in-frame rearrangement of its κ or λ IgL loci, resulting in its expression of 
surface IgM (Kitamura et al., 1991).  
1.2.2 Extramedullary development 
The developing B cell pool carries an important autoreactive potential (Janeway, Travers, 
& Walport, 2001). A 2003 report estimated that 55-75% of early immature B cells 
displayed detectable self-reactivity, through an analysis of the Igµ complementarity-
determining region (CDR)-3 (Wardemann et al., 2003). In the BM, BCR-mediated 
recognition of multivalent self-Ags induces RAG1/2 re-expression in IgM+ B cells, in an 
attempt to generate non-self-reactive BCRs—a process known as receptor editing. Failure 
to abolish self-reactivity of the BCR results in apoptosis (Tiegs, Russell, & Nemazee, 
1993). Following their negative selection in the BM, immature B cells enter the transitional 
stages—termed T1 and T2 (Allman et al., 2001). Guided by chemotactic signals, such as 
increased levels of sphingosin-1-phosphate (SIP) in vasculature, T1 B cells enter into 
circulation via BM sinusoids (Chung, Silverman, & Monroe, 2003; Pappu et al., 2007). En 
route to the secondary lymphoid organs (SLOs), B220+AA4.1+ T1 B cells are once again 
subjected to negative selection—as binding of the BCR to soluble Ags in the blood results 
in B cell anergy (Allman et al., 2001; Goodnow et al., 1988). Upon entry into the 
periarteriolar lymphoid sheet, T1 cells mature into CD23+CD21+ T2 B cells, which are 
found within the follicle (Chung et al., 2003; Loder et al., 1999). The T2-mature B cell 
transition appears to be reliant upon the positive selection of T2 cells via the B cell 
activating factor (BAFF) and strong BCR signaling (Chung et al., 2003; Pillai & Cariappa, 
2009; Schiemann et al., 2001). Long-lived mature B cells may then re-enter into 
circulation, relying on CCL21 and CCL19 gradients to guide their diapedesis back into 
SLOs [Reviewed in (Stein & Nombela-Arrieta, 2005)].  
1.3 Mature B cell subsets 
Mature B cells display an astounding degree of phenotypic and functional heterogeneity—
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and have, on the basis of their differences, been categorized into various populations and 
subsets. Major subsets have been outlined in this section. 
1.3.1 B-1 cells 
B-1 cells constitute a unique population of B lymphocytes which localize primarily within 
pleural and peritoneal cavities, and exhibit the cell surface phenotype IgMhiIgDloCD23-
CD21lo (Kantor & Herzenberg, 1993). The identification of this distinct subset was 
prompted by reports describing the presence of ‘natural’ antibodies (nAbs)—antibodies 
which displayed broad self-reactivity and occurred in the absence of exogenous antigen 
exposure (Holodick, Rodríguez-Zhurbenko, & Hernández, 2017). Some level of 
heterogeneity exists within the B-1 subset, which has been further subdivided into B-1a 
(CD5-expressing) and B-1b (CD5-lacking) fractions (Berland & Wortis, 2002). While 
peritoneum-derived B-1 cells can express CD11b, spleen-resident B-1 cells extinguish 
expression of this marker (Ghosn, Yang, Tung, Herzenberg, & Herzenberg, 2008). B-1 
cells have, since their discovery by Hayakawa and colleagues, been implicated in several 
key immune processes—such as protection against microbial infection, B cell development 
and apoptotic cell clearance (Baumgarth, 2010; Holodick et al., 2017).  
The biology of B-1 cells diverges from that of conventional B lymphocytes in many 
important aspects. With regards to development of the B-1 population, the weight of 
available evidence points to a switch in the origin of these cells from de novo hematopoietic 
development in the fetal liver to self-renewal in the adult peritoneal and pleural cavities [as 
Reviewed in (Baumgarth, 2010)]. In terms of activation and function, B-1 cells are 
considered T-cell independent (TI), as they are capable of mounting a predominately IgM-
driven response to mitogenic stimuli or repetitive polysaccharide epitopes, in the absence 
of T cell help (Mond, Lees, & Snapper, 1995; Morris & Rothstein, 1993). B-1-derived 
antibodies display reduced junctional diversity, resulting in a more restricted BCR 
repertoire relative to that of conventional B-2 cells (Feeney, 1990; Mercolino, Arnold, 
Hawkins, & Haughton, 1988). While many have deemed B-1 cells to possess innate-like 
character, reports have demonstrated the ability of B-1b cells to generate long-lasting 
protection against bacterial pathogens—a hallmark of the adaptive immunity (Alugupalli 
et al., 2004; Haas, Poe, Steeber, & Tedder, 2005). 
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1.3.2 B-2 cells 
1.3.2.1 FO B cells 
While the B-2 B cell compartment is formally comprised of both follicular (FO) and 
marginal zone (MZ) B cells, the term B-2 has been used more narrowly to differentiate 
between ‘conventional’ FO B cells, and the B-1 fraction. FO B cells, which co-express IgD 
and IgM, can further be identified on the basis of CD23 and CD21 expression 
(CD23+CD21+) (Baumgarth, 2004). Following their maturation from precursor transitional 
subsets, as outlined in Section 1.2.2., FO B cells spend most of their lifespan recirculating 
and transiting between secondary lymphoid organs (SLOs)—a dynamic process which 
promotes potential antigenic encounters at various body sites. Homing of naïve B cells to 
SLOs involves their initial attachment to high endothelial venules, within which 
endothelial cells express CCL21 and CCL19 (Stein & Nombela-Arrieta, 2005). Following 
transmigration, CXCR5-expressing FO B cells relocate to the lymphoid follicle by sensing 
follicular dendritic cell-produced CXCL13 (Förster et al., 1996; Stein & Nombela-Arrieta, 
2005). Their location within B cell follicles places naïve B cells in ideal proximity to the T 
cell zone for future cognate pair interactions (Pillai & Cariappa, 2009). Humoral responses 
driven by FO B cells are ultimately T cell-dependent—as the process of FO B cell 
activation requires T cell-derived signals (Section 1.4.1) (Parham, 2015). Processes 
relating to FO B cell antigen processing, BCR signaling, germinal center entry and terminal 
differentiation are outlined in Section 1.4. The current understanding regarding FO B cell 
responses is summarized in Figure 1-1. 
1.3.2.2 MZ B cells 
The marginal zone (MZ) of the spleen, located at the anatomic boundary of red and white 
pulp, is home to a distinct subtype of mature B lymphocytes (Kraal, 1992). These MZ B 
cells differ from their conventional B cell counterparts in a number of ways—having 
previously been denoted as an ‘innate-like’ subset of B lymphocytes (Cerutti, Cols, & 
Puga, 2013). While FO B cells bear unique BCRs of narrow specificity on their surface, 
MZ B cells possess polyreactive receptors which recognize both self and microbial 
epitopes (Cerutti et al., 2013).  
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Figure 1-1. Overview of current paradigm for T cell-dependent follicular B cell fate 
decisions. Following interactions with primed T cells, activated FO B cells can 
differentiate into short-lived antibody-secreting cells (ASCs), GC-independent memory B 
cells, or go on to form GCs. While in the GC, B cells undergo class-switch recombination 
and affinity maturation. Ultimately, GC B cells may terminally differentiate into plasma 
cells, or differentiate into memory B cells. 
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In addition to their semi-invariant BCRs, mature MZ B cells express high levels of toll-
like receptors (TLRs), and exhibit an IgMhiCD38hiCD21hiCD23- cell surface phenotype 
(Oliver, Martin, & Kearney, 1997; Treml et al., 2007).  
The positioning of these non-circulating B lymphocytes within highly perfused regions of 
the spleen has long been thought critical to their function as antibody-forming sentinels, 
which constantly screen for blood-borne pathogens (Martin & Kearney, 2002). The 
activation profile of MZ B cells differs from that of FO B cells in a few key aspects. Unlike 
FO B cells, MZ B cells can recognize and are primarily activated by T cell-independent 
antigens (Balazs, Martin, Zhou, & Kearney, 2002). When stimulated with TLR-4 ligand 
lipopolysaccharide (LPS), MZ B cells were shown to proliferate to a greater degree than 
FO B cells, but fared relatively poorly when cultured with anti-IgM antibodies (Oliver, 
Martin, Gartland, Carter, & Kearney, 1997). Exposure to LPS primarily induced secretion 
of IgM and IgG3 antibodies (Oliver, Martin, Gartland, et al., 1997). MZ B cells display 
robust antigen-presentation activity to T cells in vitro—meaning that these cells may be 
involved in both T cell-dependent and -independent responses (Martin & Kearney, 2002). 
Activation of MZ B cells prompts their re-positioning towards the white pulp of the spleen, 
where they rapidly differentiate into PCs (Bendelac, Bonneville, & Kearney, 2001). The 
rapidity of the MZ B cell antibody response lends support to innate defenses during the 
time delay occurring between the onset of primary infections, and the production of high 
affinity antibodies by FO B cells (Cerutti et al., 2013). 
1.4 Humoral immune responses 
1.4.1 T cell-dependent B cell activation 
Within lymphoid follicles, naïve B cells are continually exposed to free antigens from 
lymphatic fluid or blood, as well as to lymph-borne microorganisms captured by 
subcapsular sinus macrophages or follicular dendritic cells (FDCs) (Carrasco & Batista, 
2007; Junt et al., 2007; Phan, Grigorova, Okada, & Cyster, 2007). Monomeric or 
multimeric antigens induce cross-linking (or clustering) of BCRs on the cell surface, 
triggering the activation of downstream signaling networks. BCR engagement results in a 
phosphorylation cascade which, in its initiating stages, involves the heterodimeric Igα and 
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Igβ subunits, the Src family kinase Lyn and the spleen tyrosine kinase (Syk) (Cheng et al., 
1995; Flaswinkel & Reth, 1994). Scaffold proteins such as B cell linker protein (Blnk) 
coordinate the involvement of other downstream cellular networks, such as 
phosphoinositide-3-kinase (PI3K) and mitogen-activated protein kinases (MAPK) 
pathways (Richards, Davé, Chou, Mamchak, & DeFranco, 2001). Recruitment of Bruton’s 
tyrosine kinase (Btk) by PI3K activation further leads to an influx of Ca2+—the magnitude 
and duration of which ultimately instructs the activation of the NFκB and NF-AT pathways 
(Dal Porto et al., 2004). Signaling through the BCR results in gene expression changes 
which promote the transition from the naïve phenotype to that of antigen-experienced B 
cells. Notably, B cells upregulate CD69, an early marker of activation, and downregulate 
sphingosine-1-phosphate (SIP) receptor 1, which enables their sensing of chemotactic SIP 
gradients, thus preventing their egress into circulation (Lo, Xu, Proia, & Cyster, 2005; 
Richards et al., 2001). 
In addition to inducing the signaling cascade outlined above, BCR engagement 
concurrently coordinates antigen internalization, by the process of receptor-mediated 
endocytosis (Hou et al., 2006). Antigen acquisition can occur via the direct binding of free 
antigen (soluble proteins of low molecular weight) by the BCR, or through the formation 
of a synapse between B cells and antigen-presenting cells (APCs) displaying tethered 
antigens or microorganisms (Batista, Iber, & Neuberger, 2001). Bound antigen are 
internalized in a clathrin-dependent manner, and directed to multivesicular compartments 
for proteolytic processing and loading onto MHC Class II molecules (Avalos & Ploegh, 
2014; Cheng, Steele, Gu, Song, & Pierce, 1999). Following transport of peptide-MHC class 
II (pMHCII) complexes to the cell surface, relocalization of antigen-experienced B cells is 
initiated within the follicle in an EBI2 and CCR7-dependent manner (Gatto et al., 2009; 
Okada et al., 2005; Rock, Benacerraf, & Abbas, 2007). Expression of CCR7, which enables 
sensing of T cell-derived CCL19 and CCL21, prompts the chemotactic migration of 
follicular B cells towards the boundary of the T and B cell zones, known as the 
interfollicular region (Kerfoot et al., 2011; Reif et al., 2002). The interfollicular zone 
subsequently becomes the stage upon which long-lived cognate interactions between 
committed CD4+ Tfh cells and antigen-engaged B cells take place—interactions which 
depend primarily on binding of B cell-borne pMHCII complexes with T cell receptors 
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(TCR) (Kerfoot et al., 2011; Lanzavecchia, 1985; Okada et al., 2005).  
High affinity recognition of pMHCII complexes by TCRs initiates a series of complex 
cellular crosstalk between cognate pairs, driving subsequent cellular differentiation events. 
Notably, B cell expression of the inducible co-stimulator (ICOS) ligand promotes T cell 
differentiation into the Tfh phenotype (Crotty, 2014). Co-stimulation of B cells via 
CD40L/CD40 interactions and T cell–secreted IL-21 results in downstream activation of 
both canonical and non-canonical NFκB pathways—promoting B cell survival and 
proliferation (Lu et al., 2007; Okada et al., 2005) This crosstalk ultimately induces, in a 
subset of B cells, the expression of B cell lymphoma 6 (BCL-6)–widely regarded as a key 
regulator of GC initiation and maintenance (Dent, Shaffer, Yu, Allman, & Staudt, 1997). 
1.4.1.1 Germinal centre reactions 
While plasma and memory cells have previously been shown capable of arising at 
extrafollicular locations, the responding pool of high-affinity, class-switched antigen-
experienced B cells is generally understood to derive predominantly from GC reactions 
(Kimoto et al., 1997; Liu et al., 1996; Taylor, Pape, & Jenkins, 2012). GCs are specialized 
microanatomical niches which are established by the intrafollicular seeding and clonal 
expansion of activated B cells, and enable antigen-specific B cells to undergo class-switch 
recombination and affinity maturation (Jacob, Kelsoe, Rajewsky, & Weiss, 1991; Liu et 
al., 1996; Victora & Nussenzweig, 2012). GCs arise following the sustained formation of 
cognate T and B cell interactions, resulting in the expression of the transcriptional repressor 
B cell lymphoma 6 (Bcl-6) in a subset of antigen-engaged B cells and committed T 
follicular helper (Tfh) cells (Dent et al., 1997). Establishment and maintenance of GCs 
necessitates Bcl-6 induction in responding B cells—a process which appears to be jointly 
regulated in the early stages of GC initiation by MEF2B and IRF4 (Fukuda et al., 1997; 
Ochiai et al., 2013; Ying et al., 2013). Bcl-6 maintains the GC gene expression program 
through both direct repression of genes promoting alternative fates (i.e. Blimp-1) and 
microRNA-dependent regulation of key GC factors, such as activation-induced cytidine 
deaminase (AID) (Basso et al., 2012; Crotty, Johnston, & Schoenberger, 2010; Ochiai et 
al., 2013). 
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The GC can be divided, on the basis of both microanatomy and function, into the dark and 
light zones (DZ/LZ). Within the dark zone of the GC, rapidly cycling B cells accumulate 
point mutations in the variable regions of B cell receptor (BCR)-encoding immunoglobulin 
genes (Allen et al., 2004). In centroblasts, AID-mediated deamination of cytidine residues 
results in a high rate of single nucleotide substitutions which, rather intuitively, seem to 
cluster within complementarity-determining regions (Di Noia & Neuberger, 2007). This 
stochastic process, known as somatic hypermutation (SHM), serves to diversify the range 
of antigenic affinities exhibited by GC B cells, prior to their entry into the light zone for 
selection (LZ). An early theory of affinity maturation, which has since found support in 
recent studies, proposed that selection of GC B cells in the LZ was based upon BCR 
affinities—with high affinity B cells acquiring survival signals through CD40 ligation, and 
low affinity centrocytes undergoing apoptosis (Gitlin, Shulman, & Nussenzweig, 2014; 
MacLennan, 1994; Shinnakasu & Kurosaki, 2017).  
While expression of CXCR4 (receptor for CXCL12) maintains CD83loCD86lo centroblasts 
in the DZ, a switch to cell surface expression of CXCR5 mediates their entry into the LZ, 
by rendering these cells sensitive to CXCL13 chemotactic signals (Allen et al., 2004; Allen, 
Okada, Tang, & Cyster, 2007). Upon their re-localization, these GC B cells become known 
as centrocytes, and constitute a population of non-proliferative cells which express a 
modified BCR of yet unknown antigenic affinity. The LZ of the GC is comprised of Tfh 
cells and follicular dendritic cells (FDCs), which play a critical role in the selection of 
centrocytes undergoing affinity maturation, and in the maintenance of the GC 
microarchitecture (De Silva & Klein, 2015a). FDCs are capable of antigen capture by 
means of a variety of receptors, including complement receptors CD21/35, as well as the 
low-affinity Fcγ receptor CD32, which enable them to bind immune complexes [Reviewed 
in (Allen & Cyster, 2008)]. In recent years, significant advances in our understanding of 
Tfh cells have underscored these cells’ substantial contribution to both GC B cell selection 
and the onset of memory responses (Ise et al., 2014). Within the LZ, Tfh cells provide ‘help’ 
to centrocytes—a catch-all term denoting an assortment of cytokine signals, such as IL-21, 
along with direct cell-to-cell contact via, namely, CD40/CD40L and major 
histocompatibility complex class II (MHC II)-T cell receptor (TCR) interactions (Ise et al., 
2014). 
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As our understanding currently stands, centrocytes acquire antigens, which may be 
displayed on FDCs, and present processed peptides to Tfh cells, in order to acquire survival 
and proliferation signals. By using a delivery system allowing for dose titration of antigen 
to GC B cells, Gitlin et al. demonstrated that centrocyte affinity corresponds to the 
magnitude of T cell help and subsequent cycles of cell divisions in the DZ (Gitlin et al., 
2014). Entry into the LZ ultimately presents three possible outcomes for centrocytes—that 
of 1) intrazonal recirculation, which subjects GC B cells to additional rounds of SHM or 
CSR, 2) of apoptosis, or 3) of GC exit by means of differentiation (De Silva & Klein, 
2015a).  
1.4.1.2 Memory & effector functions 
1.4.1.2.1 Plasmablasts and plasma cells 
Plasma cells (PCs) specialize in the constitutive production and secretion of antibodies, 
which promote the resolution of ongoing infections and provide a baseline layer of 
protection against re-infection (Moser, Tokoyoda, Radbruch, MacLennan, & Manz, 2006). 
In contrast to MBCs, which rapidly reactivate and enter a proliferative state upon secondary 
antigenic exposure, PCs are post-mitotic and terminally differentiated (Moser et al., 2006). 
Antibody-forming PCs are distinguishable by their surface expression of CD138 
(syndecan-1), absent or low expression of common B cell markers such as CD19 and B220 
and their elongated morphology, dominated by an overdeveloped endoplasmic reticulum 
and golgi apparatus (Costes et al., 1999; Ribourtout & Zandecki, 2015; Wijdenes et al., 
1996). While many still consider PCs to have extinguished surface Ig expression, recent 
work by Blanc and colleagues demonstrates that BM-resident IgM+ PCs, unlike their IgG-
producing counterparts, retain BCR expression along with the ability to sense the presence 
of their respective antigens (Blanc et al., 2016). 
The term plasmablast has been used in the literature to describe both short-lived antibody-
secreting cells and actively cycling plasma cell precursors (Fooksman et al., 2010; Nutt, 
Hodgkin, Tarlinton, & Corcoran, 2015). These divergent definitions may lead to confusion 
in the context of extrafollicular PCs, which are produced independently of GC reactions 
and have a short half-life of 3 to 5 days (Ho, Lortan, MaClennan, & Khan, 1986). 
Plasmablasts (PBs) and PCs are often jointly referred to under the umbrella of ‘antibody-
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secreting cells’ (ASCs). Level of cell-surface CD138, or intracellular Blimp-1 expression, 
have been used as a basis of discrimination between these subsets (Shi et al., 2015). While 
PBs are found in secondary lymphoid tissues, such as the splenic red pulp and lymph nodes 
medullary cords, long-lived PCs take up their primary residence in the BM (Benner, 
Hijmans, & Haaijman, 1981). This homing process has been shown to partially depend on 
the upregulation of CXCR4, receptor for the BM stromal cell-produced CXCL12, along 
with concomitant downregulation of CXCR5 and CCR7 (Hargreaves et al., 2001). Though 
PC longevity remains incompletely understood, some have shown that certain BM niches 
permit the interplay of PCs and eosinophils, which can provide signals to promote PC 
persistence (Chu et al., 2011; Moser et al., 2006). The expression of CD138 has 
additionally been shown to be important in rendering PCs sensitive to pro-survival signals, 
namely IL-6 and APRIL (McCarron, Park, & Fooksman, 2017). 
PB and PCs emerging from GCs are often class-switched (De Silva & Klein, 2015a). The 
novel effector functions conferred by secondary isotypes serve to direct the Ab response to 
various locations and against certain types of pathogens. Readily produced, yet typically 
low affinity pentameric IgM molecules are particularly protective against bacteremia—due 
to their ability to fix complement in circulation (Janeway, Travers, Walport, & Shlomchik, 
2001). IgG and IgA antibodies are both potent neutralizers, and can easily diffuse into 
bodily tissues (Vidarsson et al., 2014). The IgG subclasses constitute the most abundant 
isotype found in serum, as they act to neutralize and opsonize pathogens, activate 
complement, promote Ab-dependent cell-mediated cytotoxicity (ADCC), and may cross 
the placental barrier to provide passive protection to the fetus (Diebolder et al., 2014; 
Niewiesk, 2014; Tang et al., 2007; Vidarsson et al., 2014). Dimeric IgA can cross the 
epithelium at mucosal sites, where it prevents the attachment of bacteria and the binding 
of viruses, and neutralizes bacterial toxins (Apter, Lencer, Finkelstein, Mekalanos, & 
Neutra, 1993). Though the function of IgE antibodies are notoriously linked to the allergic 
response, their ability to elicit mast cell degranulation to trigger a range of expulsive 
responses renders them protective against helminth infections (Fitzsimmons, Falcone, & 
Dunne, 2014). 
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1.4.1.2.2 Memory B cells 
During primary immune responses, the establishment of mature GCs in lymphoid follicles 
may take up to seven days (De Silva & Klein, 2015a). This period of delay between first 
antigen encounter and antibody production is owed partly to the many required processes 
leading up to the induction of adaptive immune responses—including those of dendritic 
cell (DC) maturation and migration, T cell activation, T-B cell cognate interactions and 
eventually seeding of the lymphoid follicle by Bcl6-expressing B and T cells (Parham, 
2015). By contrast, subsequent exposures to a given immunogen are known to more rapidly 
give rise to high affinity antibodies of class-switched isotypes (Ahmed & Gray, 1996). This 
important property of adaptive immune responses is attributable to a population of long-
lived, ‘rapid responder’ MBCs generated during a primary response (Kurosaki et al., 2015).  
The body of knowledge regarding MBCs has long been dominated by the study of human 
MBCs, which have classically been identified by their cell-surface expression of CD27 and 
IgD (Agematsu et al., 1997). Transcriptomic comparisons of naïve and memory B cells 
have highlighted many similarities between these subsets, but have failed to identify 
transcription factors involved in driving memory identity (Good & Tangye, 2007; 
Tomayko et al., 2008). The identification of murine MBCs must thus rely on established 
functional characteristics—namely, their metabolic quiescence, antigen-experienced 
status, persistence and ability to generate secondary antibody-forming responses upon re-
challenge, following adoptive transfer (MaClennan & Gray, 1986; Suan, Kräutler, et al., 
2017; Zuccarino-Catania & Shlomchik, 2015). Surrogate phenotypic markers—such as 
evidence of class-switching (IgG1+), exclusion of GC cells and PCs, and model antigen 
specificity—are employed experimentally in defining cells which have acquired a memory 
phenotype (Weisel, Zuccarino-Catania, Chikina, & Shlomchik, 2016). The use of such 
markers, however, generally precludes the analysis of pre-existing (non-model antigen 
specific) or non-class-switched (IgM+) MBCs (Dell, Lu, & Claflin, 1989). 
Despite the prevalent view that the differentiation of GC B cells is a dichotomous decision 
between effector and memory fates, the factors governing the generation of MBCs remain 
elusive (Suan, Sundling, & Brink, 2017). At the level of transcriptional regulation, 
induction of the transcription factor Bach2 has been shown to play a critical role in the 
 
 
 16 
generation of MBCs (Ochiai et al., 2006; Shinnakasu & Kurosaki, 2017). Multiple reports 
have outlined a role for BCR affinity in influencing the differentiation of PCs and MBCs, 
by demonstrating a bias of high-affinity cells in the PC pool and of low-affinity cells in the 
MBC compartment (Kräutler et al., 2017; Phan et al., 2006; Shinnakasu et al., 2016). The 
enrichment of somatic mutations observed in the PC compartment, relative to the long-
lived MBC fraction, is supported by work by Weisel and colleagues, which suggests that 
memory B cells arise as early by-products of GC reactions (Weisel et al., 2016). Recent 
work by Suan and colleagues has identified a population of CCR6-expressing MBC 
precursors within the LZ of the GC (Suan, Sundling, et al., 2017). These MBC precursors 
were found to be a quiescent population carrying a relatively low burden of mutations 
within VDJ loci—further supporting a model of low-affinity GC B cell-derived MBCs 
(Suan, Sundling, et al., 2017). Expression of CCR6 appears to be of functional relevance 
within MBC compartment, as its loss incurs defects in secondary antibody-forming 
responses and alters the localization of these cells in the spleen (Elgueta et al., 2009). 
1.4.2 T cell-independent responses 
T cell-dependent B cell responses are generally mounted against protein antigens, owing 
to MHC restriction in T cells (Parham, 2015). However, certain B cells subsets, namely 
comprising the B-1 and MZ compartments, do not require T cell assistance in completing 
their activation, and in inducing their differentiation into antibody-secreting cells. These T 
cell-independent (TI) responses, otherwise known as thymus-independent, can be 
generated against two primary classes of antigens, denoted as TI-1 and TI-2. TI-1 antigens 
are mitogens capable of inducing B cell activation without need for direct interactions with 
the BCR, such as LPS (Jeurissen, Ceuppens, & Bossuyt, 2004). TI-1 antigens are 
polyclonal, as they can induce activation irrespective of BCR specificity (Jeurissen et al., 
2004). By contrast, TI-2 antigens are comprised of repetitive, multivalent structures which 
can induce BCR crosslinking, resulting in potent BCR signalling and activation in the 
absence of T cell help (Mond et al., 1995). The model antigen ficoll (which may be 
haptenated), along with numerous bacterial capsular polysaccharides, stand as prototypic 
examples of TI-2 antigens. The stimulatory capacities TI-2 antigens can be potentiated by 
cytokines, such as interferon-γ (Mond et al., 1995). 
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For many years, TI B cell responses were believed to be incompatible with the generation 
of memory—prompting the development of glycoconjugate vaccines against pathogens 
such as Haemophilus influenzae type B and Neisseria miningitidis (Goldblatt, 2000). These 
vaccines capitalized on the concept of linked recognition, whereby a weak polysaccharide 
immunogen is conjugated to an immunogenic protein antigen (Goldblatt, 2000). 
Polysaccharide-specific B cells can thus bind and internalize the conjugated molecule, and 
present peptides to obtain T cell help (Parham, 2015). Some reports, however, have 
indicated that TI memory cells can indeed be formed following exposure to TI antigens 
(Alugupalli et al., 2004; Obukhanych & Nussenzweig, 2006). Though these TI MBCs 
present phenotypic differences relative to their T cell-dependent counterparts, they appear 
to be of similar longevity and can be class-switched (Obukhanych & Nussenzweig, 2006). 
1.5 Transcriptional regulation in B cells 
1.5.1 E26-transformation specific transcription factors 
The E26-transformation specific (Ets) family of transcription factors is comprised of over 
20 members in mice—so categorized on the basis of their shared ‘Ets’ DNA-binding 
domain (Bult et al., 2008; Foos & Hauser, 2004). This Ets DNA-binding domain, first 
identified as belonging to a protein of the avian leukemia retrovirus E26, enables DNA-
protein interactions via a helix-turn-helix motif (Hollenhorst, McIntosh, & Graves, 2011). 
Ets factors share a high affinity for consensus 5’-GGA(A/T)-3’ sequences, upon which 
they may act as transcriptional activators or repressors (Oikawa & Yamada, 2003). The 
expression of Ets family members in many mammalian species, tissues types has been the 
subject of extensive characterization [Reviewed in (Oikawa & Yamada, 2003)]. While the 
expression of some Ets factors is near ubiquitous, certain members exhibit more lineage-
restricted patterns—as is the case for factors of the SPI subfamily, discussed in the 
following sections (Hollenhorst et al., 2011). 
1.5.1.1 PU.1 and Spi-B 
The highly-related Ets transcription factors PU.1 (Spi1) and Spi-B (Spib) have widely been 
implicated in the differentiation and function of the myeloid and lymphoid lineages 
(McKercher et al., 1996; Scott et al., 1997; Scott, Simon, Anastasi, & Singh, 1994). PU.1 
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and Spi-B exhibit an extensive degree of structural similarity, owing to their 43% shared 
amino acids (Ray et al., 1992). Like other members of the Ets family, PU.1 and Spi-B can 
interact with the purine rich, core PU-box (GGAA/T) motif as monomers, or can recruit 
co-factors to activate transcription of their target genes (Sharrocks, 2001). Recruitment of 
the well-characterized PU.1 binding partner interferon regulatory factor 4 (IRF-4, also 
known as Pip) at ETS-IRF composite elements (EICE) occurs following the 
phosphorylation of serine residues in the proline, glutamine, serine and threonine (PEST) 
region of PU.1 and Spi-B (Perkel & Atchison, 1998). While early studies had suggested 
the binding specificities of PU.1 and Spi-B to be identical, genome-wide approaches have 
revealed sites bound uniquely by one factor or the other, despite an extensive overlap in 
occupancy patterns (Solomon, Li, Piskorz, Xu, & DeKoter, 2015). 
With over 110 gene targets identified to date, PU.1 acts as an activator of transcription for 
several genes and microRNAs, including the macrophage colony-stimulating factor (M-
CSF), IgH and IgL loci [Reviewed in (Turkistany & Dekoter, 2011)]. PU.1 expression 
levels have a dramatic impact on the differentiation of early hematopoetic progenitors—
with high levels of PU.1 promoting myeloid differentiation in lymphoid-myeloid 
progenitors, and low PU.1 levels favoring the B lymphocytic fate in the BM (DeKoter & 
Singh, 2000). By contrast, Spi-B expression is restricted primarily to the B lymphoid 
lineage, in which it coordinates the induction of genes involved in BCR signalling, such as 
that of Blnk, Syk and Grap2 (Bednarski et al., 2016; Garrett-Sinha et al., 2005). In addition 
to being detected at high levels in B cells, Spi-B expression has been implicated in 
plasmacytoid DC development (Schotte et al., 2003; Su et al., 1996, 1997).  
Despite their highly homologous structures and numerous functional redundancies, the 
expression of Spi-B cannot compensate for a lack of PU.1. Independently-generated mouse 
strains homozygous for non-functional alleles of PU.1 (Sfpi-/-) die during gestational 
development, or immediately postnatally, and fail to generate B cells and macrophages 
(McKercher et al., 1996; Scott et al., 1994). By contrast, Spi-B knockout mice are able to 
generate mature B cells capable of mounting normal antibody-forming responses, 
following T cell-dependent immunization (Su et al., 1997). The lack of impairment in 
primary reponses to T cell-dependent antigenic challenge is rather remarkable, considering 
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the reductions observed in both the frequencies and numbers of FO B cells in Spib-/- spleens 
(Li, Solomon, Fulkerson, & DeKoter, 2015). Despite their ability to generate functional 
primary responses, Spib-/- B cells exhibit proliferation defects in response to BCR 
stimulation—a defect compounded in Sfpi+/-Spib-/- B cells, which harbour a complete 
deficiency of Spi-B combined with heterozygous loss of PU.1 (Garrett-Sinha et al., 1999; 
Li et al., 2015; Su et al., 1997). Su et al. have further reported impairments in Spib-/- 
secondary antibody-forming responses, namely with regards to decreased IgG1, IgG2a/c and 
IgG2b titres, following prime and boost immunization with haptenated model antigens. 
Correspondingly, Spib-/- mice were shown to have poorly  sustained splenic GCs 28 days 
post-immunization (d.p.i.), relative to WT mice (Su et al., 1997). This phenotype was 
exacerbated in Sfpi1+/-Spib-/- mice, which failed to generate splenic GCs at 10 or 28 d.p.i. 
(Garrett-Sinha et al., 1999). 
Multiple lines of evidence converge to suggest that the transcriptional regulation exerted 
by PU.1 and Spi-B suppresses the plasmacytic potential of activated B cells (Carotta et al., 
2014; Schmidlin et al., 2008; Willis et al., 2017). By forming ternary complexes with EICE, 
IRF4/8-Ets dimers can directly enforce gene expression programs corresponding to either 
the GC or plasmacytic fates. The IRF8-PU.1 complex has previously been shown to be 
instrumental in maintaining the activated B cell program—with a loss of both IRF8 and 
PU.1 leading to markedly increased ASC differentiation following stimulation with 
CD40L and IL-4 (Carotta et al., 2014; Xu et al., 2015). Both PU.1 and Spi-B have been 
shown to be downregulated in splenic and bone marrow-derived ASCs—with Spi-B 
showing a rather marked decline in expression during the transition from GC B cells to 
splenic ASCs (Carotta et al., 2014). Concurrent and progressive loss of EICE accessibility 
over successive cell divisions further extinguishes PU.1 and Spi-B-mediated regulation in 
activated B cells (Scharer, Barwick, Guo, Bally, & Boss, 2018). A recent publication by 
Willis et al. demonstrates that loss of PU.1 and Spi-B in activated B cells results in de-
repression of PC differentiation, and corresponds to an upregulation of Prdm1, Xbp1 and 
Aicda (Willis et al., 2017). Schmidlin and colleagues have additionally reported that 
ectopic Spi-B overexpression in human B cells impairs CD138+ plasma cell generation, 
and corresponds with decreased expression of BLIMP-1 and XBP-1 (Schmidlin et al., 
2008). 
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1.5.1.2 Spi-C 
Following its isolation by two independent research groups in 1999, Spi-C (previously 
known as PU.1-related factor, or Prf) was characterized as a PU.1-related protein based on 
sequence homology and similarities in binding interactions with the PU-box motif 
(Bemark, Mårtensson, Liberg, & Leanderson, 1999; Hashimoto et al., 1999). The Ets 
DNA-BD of Spi-C exhibits 57% and 61% sequence homology with that of PU.1 and Spi-
B, respectively (Hashimoto et al., 1999). In early studies, Spi-C expression was 
demonstrated to be primarily restricted to the B cell compartment—namely in pre-B and 
mature B cells—though some expression was also detected in red pulp macrophages 
(Bemark et al., 1999; Hashimoto et al., 1999). Spi-C expression was later shown to differ 
in peritoneal and splenic CD5+ B-1a cells—being overexpressed in the latter—and was 
shown to be expressed at high levels in red pulp macrophages (Stoermann, Kretschmer, 
Düber, & Weiss, 2007). From a structural standpoint, and similarly to PU.1 and Spi-B, Spi-
C contains an N-terminus transactivation domain. Interestingly, the transactivation domain 
in Spi-C does not allow for IRF4 binding, as demonstrated by gel-shift analysis (Carlsson, 
Persson, & Leanderson, 2003).  
The role of Spi-C as a potential antagonist of PU.1, first suggested by Hashimoto et al., 
was later corroborated by several reports (Hashimoto et al., 1999). Schweitzer and 
colleagues demonstrated that Spi-C, like PU.1, is able to bind at sites within the IgH 
intronic enhancer and FcγRIIb promoter in progenitor B cells. At these sites, however, Spi-
C was shown to oppose the function of PU.1—resulting in increased sterile transcripts of 
IgH and decreased transcription of FcγRIIb, which encodes the inhibitory Fc receptor 
(Schweitzer et al., 2006). Ectopic expression of Spi-C in pro-B cells induced upregulation 
of CD25 and downregulation of c-Kit—changes which are consistent with a pre-B cell-like 
phenotype (Schweitzer et al., 2006). Zhu and colleagues successfully generated a 
transgenic mouse strain in which Spi-C expression is maintained under the control of the 
IgH intronic enhancer (Eµ). B cell-specific Spi-C overexpression of 2-5 fold was sufficient 
to result in a decrease of BM and splenic CD19+B220+ B cell frequencies, along with 
reductions in the numbers of T1, T2, T3, MZ and FO B cells (Zhu, Schweitzer, Romer, 
Sulentic, & DeKoter, 2008). Splenic B cells obtained from Spi-C transgenic animals 
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showed marked proliferation defects in response to stimulation with CD40 or via the BCR. 
Further, immunization of Eµ-SpiC transgenic mice with haptenated keyhole-limpet 
hemocyanin  resulted in a two-fold increase in IgM and two-fold decrease in IgG titres, as 
compared to WT mice (Zhu et al., 2008). These findings were the first to suggest a potential 
role for Spi-C in the generation of antibody-forming responses during infection, or 
following immunization (Zhu et al., 2008). 
Despite its antagonistic functions, Spi-C has been shown capable of complementing PU.1 
and Spi-B transcriptional activation at certain loci in B cells. Using Sfp1+/- Spib-/- (PUB) 
mice, DeKoter et al. reported that reductions in CD23+ FO B and T2 cell frequencies could 
be rescued by transgenic Spi-C expression in Eµ-Spi-C+ PUB mice (DeKoter et al., 2010). 
Spi-C was shown to directly activate transcription at the FcεR2a locus, which encodes the 
cell-surface marker CD23 (DeKoter et al., 2010). To further investigate the regulatory role 
of Spi-C in B cell development, a Spib-/-Spic+/- mouse strain was generated by Li and 
colleagues (Li et al., 2015). While concurrent loss of Spi-B and Spi-C (Spib-/-Spic-/-) proved 
to be non-viable, Spi-C heterozygosity on a Spib-/- background was shown to rescue 
reductions in both frequencies and absolute numbers of splenic FO and T2 B cells, which 
were observed in Spib-/- mice. A deficiency in Spi-C additionally rescued proliferation of 
Spib-/- B cells following stimulation by LPS or anti-IgM—a rescue mediated in part by 
restored Nfkb1 expression in Spib-/-Spic+/- mice. Spi-C was demonstrated as capable of 
binding the Nfkb1 locus, but unlike Spi-B, was unable to activate transcription at this site 
(Li et al., 2015).  
A recent study by Bednarski et al. showed that Spi-C expression is induced in pre-B cells, 
following the RAG-dependent generation of DNA double-stranded breaks (Bednarski et 
al., 2016). At this stage in B cell development, Spi-C binds regulatory regions of Syk and 
Blnk, where it repressed transcription (Bednarski et al., 2016). By blocking the 
transcription of key proteins involved pre-BCR signal transduction, Spi-C was shown 
capable of suppressing pre-BCR-mediated proliferation—in a likely attempt to promote 
cell cycle arrest at the small pre-B cell stage, which is marked by genomic instability arising 
from recombination (Bednarski et al., 2016). The above studies demonstrate the potential 
for Spi-C to act as both activator and transcription during early B cell development. Based 
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on its documented involvement in the regulation of pre-BCR and BCR signaling, Spi-C 
might feasibly be implicated in B cell fate determination at several distinct stages—
between the FO and MZ B cell subsets, or during activated B cell fate decisions between 
PCs or MBCs (Bednarski et al., 2016; Pillai & Cariappa, 2009; Zhu et al., 2008). As of yet, 
patterns of Spi-C expression throughout B cell development remain to be characterized. 
The function of the Spi-C in regulating B cell developmental programs during immune 
responses is entirely unknown. 
1.5.2 Activated B cell fate decisions 
In the GC, activated B cells must dynamically balance the pull of three opposing states: 
that of the inherently transient GC fate, that of the effector plasma cell (PC) fate, and 
finally, that of the sentinel-like memory B cell (MBC) fate. B cell exit from the GC thus 
necessitates the halting of intrazonal recirculation, followed by differentiation into PCs or 
MBCs. The molecular determinants responsible for orchestrating activated B cell fate 
commitment and regulating GC exit have become the focus of intense scrutiny (Tarlinton, 
2012). Two preeminent perspectives on the issue—the stochastic and instructive models of 
activated B cell fate decisions—are discussed below.  
Under the stochastic model of fate determination, GC B cells face a decision with every 
cellular division—to differentiate, to remain in the GC for further rounds of SHM and CSR, 
or to die—resulting in a collective probability for certain cells to undergo differentiation at 
any given time (Duffy et al., 2012; Good-Jacobson & Shlomchik, 2010). Within this 
framework, the influence of intrinsic factors, such as expression levels of key transcription 
factors, or extrinsic factors, such as the magnitude of T cell help, are resolved internally 
and autonomously for each B cell (Duffy et al., 2012; Hawkins, Turner, Dowling, van 
Gend, & Hodgkin, 2007; Tarlinton, 2012). Work in support of this model has shown that, 
while on an individual cellular level, time to division, to fate commitment or death is highly 
changeable, population level outcomes remain steady and resistant to variations across 
responses (Duffy et al., 2012). Mathematical models based on the stochastic framework, 
devised by Phil Hodgkin’s group, have shown promise in predicting the survival and 
division of stimulated B cells in vitro (Hawkins, Markham, McGuinness, & Hodgkin, 
2009; Hawkins et al., 2007). 
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In opposition to the stochastic framework of differentiation stands the instructive model, 
under which B cell fate determination primarily depends on extrinsic, Tfh-derived 
‘instructions’ (Tarlinton, 2012). In recent years, an affinity-driven model of activation-
induced B cell fate decisions has gained traction in the literature (Paus et al., 2006). In this 
model, commitment to the PC fate is initiated in high affinity, LZ-resident B cells, and is 
dependent upon signals from Tfh cells (Kräutler et al., 2017; Paus et al., 2006). Work by 
Shinnakasu and colleagues has suggested that high affinity B cells receive correspondingly 
strong T cell help, which promotes the PC fate via downregulation of the transcriptional 
repressor Bach2 (Shinnakasu et al., 2016). Similarly, strong T cell help has been shown to 
result in the degradation of Cbl ubiquitin ligase—leading to de-repression of IRF4 and PC 
differentiation (Li et al., 2018). Ultimately, the instructive model seems intuitive, in that 
the long-lived and post-mitotic PC compartment is given priority in terms of high-affinity 
cells. MBCs, which are bound to re-establish secondary GCs upon reactivation, need only 
to remain able to bind their antigen—and can therefore bear BCRs of relative lesser affinity 
(Kurosaki et al., 2015). 
1.5.2.1 Blimp-1 & Bcl6 
The gene regulatory network comprised of Blimp-1 and Bcl-6 has long been known to play 
a critical role in the tug-of-war of gene expression between the GC B cell and PC fates. 
These transcription factors are widely viewed as exerting opposing pressures on activated 
B cells—with Bcl-6 maintaining the GC gene expression program, and Blimp-1 promoting 
terminal differentiation of B cells into antibody-secreting cells (ASCs) (Shaffer et al., 
2002).  
Blimp-1, or B lymphocyte-induced maturation protein-1 (encoded by Prdm1), is a C2H2-
type zinc finger transcriptional repressor which has been identified as a master regulator of 
terminal B cell differentiation (Keller & Maniatis, 1992; Turner, Mack, & Davis, 1994). 
Early work showed that expression of Blimp-1 was restricted to the activated B cell and 
PC compartment, and was activated early in the process of differentiation from B cells to 
ASCs (Angelin-Duclos, Cattoretti, Lin, & Calame, 2000; Turner et al., 1994). Ectopic 
expression of Blimp-1 in lymphoma cells resulted in increased cell size, Ig secretion and 
expression of CD138—important features of the PC phenotype (Turner et al., 1994). 
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Blimp-1 has since been shown to directly repress Myc, thus arresting intrazonal 
recirculation in the GC, along with Pax5 and MHC class II transactivator (CIITA), which 
coordinates the silencing of B cell gene expression patterns (Lin, Angelin-Duclos, Kuo, & 
Calame, 2002; Lin, Wong, & Calame, 1997; Piskurich et al., 2000). PC differentiation is 
further supported by the indirect induction of Xbp-1 by Blimp-1, which is thought to 
promote antibody synthesis and secretion via regulation of the unfolded protein response 
(Tellier et al., 2016). Of note, Blimp-1 has additionally been shown to repress Spi-B, which 
acts as a negative regulator of plasma cell differentiation (Schmidlin et al., 2008; Shaffer 
et al., 2002). While germline knockouts of Blimp-1 are non-viable, a conditional model of 
Blimp-1 deletion in CD19-expressing mature B cells showed that Prdm1-/- mice exhibit 
profound defects in the PC compartment—in terms of both PC frequencies and Ig titers 
following immunization (Shapiro-Shelef et al., 2003).  
By contrast, the generation and maintenance of GCs necessitates Bcl-6 expression (Crotty 
et al., 2010; Dent et al., 1997; Fukuda et al., 1997). Similarly to Blimp-1, B cell lymphoma-
6 (encoded by Bcl6) is a Krüppel-type zinc finger-containing transcriptional repressor. First 
identified through its implication in diffuse large B cell lymphoma, Bcl6 is expressed at 
high levels in GC B cells and Tfh cells to promote their survival and proliferation (Crotty 
et al., 2010; Ye et al., 1993). Though the mention of Bcl6 seems for many intrinsically 
linked to the GC, the factor plays an important role in early B cell development 
(Swaminathan, Duy, & Müschen, 2014). In GC B cells, Bcl6 directly represses Prdm1, and 
drives the processes of SHM and CSR through its indirect induction of AID (encoded by 
Aicda) (Basso et al., 2012; Toyama et al., 2002). Conditional deletion of Bcl6 in 
lymphocytes leads to humoral responses in which MBCs can be produced, despite a 
complete lack of GCs, and severe defects in the generation of long-lived PCs are observed 
(Toyama et al., 2002). 
1.5.2.2 IRF4 & IRF8 
The interferon regulatory factors 4 and 8 (IRF4 / IRF8) are related transcription factors 
belonging to the IRF superfamily which bind, by virtue of their tryptophan-rich helix-turn-
helix DNA binding domain, to conserved IFN-stimulated response elements (ISRE) 
(Yanai, Negishi, & Taniguchi, 2012). Both IRF4 and IRF8 have shown to be capable of 
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homodimerization and heterodimerization with other IRF factors and Ets family members 
(Shukla & Lu, 2014). The diverse range of potential protein-protein interactions involving 
IRF4 and IRF8 likely contributes to their numerous functions in B cells—including early 
B cell development, tolerance induction and ultimately fate commitment (Lu, Medina, 
Lancki, & Singh, 2003; Pathak, Ma, Trinh, & Lu, 2008; Xu et al., 2015). 
More recently, Harinder Singh’s group has identified an important role for the IRF4 and 8 
in governing the fate of activated B cells in a concentration-dependent manner (Xu et al., 
2015). High abundance of IRF4 (paired with low levels of IRF8 expression) favours the 
generation of PBs and PCs, while high IRF8 and correspondingly low IRF4 expression 
favour the GC fate (Xu et al., 2015). This study supports previous reports regarding the 
importance of graded IRF4 expression in antigen-experienced B cells. High level IRF4 
induction immediately following B cell activation are necessary for the establishment of 
GCs (Willis et al., 2014).  
Interactions between IRF and Ets factors have long been documented (Eisenbeis, Singh, & 
Storb, 1995). By forming ternary complexes with ETS-IRF composite elements (EICE), 
IRF4/8-Ets dimers can directly enforce gene expression programs corresponding to either 
the GC or plasmacytic fates. The IRF8-PU.1 complex has previously been shown to be 
instrumental in maintaining the activated B cell program—with a loss of both IRF8 and 
PU.1 leading to markedly increased ASC differentiation following stimulation with 
CD40L and IL-4 (Carotta et al., 2014; Xu et al., 2015). The ability of PU.1 and Spi-B to 
interact with both IRF4 and IRF8 in order govern activation-induced B cell decisions seems 
somewhat paradoxical, given reports of PU.1 and Spi-B acting as negative regulators of 
plasma cell differentiation (Carotta et al., 2014; Schmidlin et al., 2008). Both PU.1 and 
Spi-B have been shown to be downregulated in splenic and bone marrow-derived ASCs—
with Spi-B showing a rather marked decline in expression during the transition from GC 
B cells to splenic ASCs (Carotta et al., 2014). The reductions in PU.1 and Spi-B expression 
seem to correspond with periods of dominant IRF4 expression in B cells, and may thus fit 
with the dominantly negative regulatory effect exerted by the Ets factors during activated 
B cell fate decisions. Thus, PU.1 and Spi-B may be preferentially co-opted during periods 
of high IRF8 expression, owing at least partly to the factors’ shared expression profile.  
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1.5.2.3 Bach2 
The related BTB Domain and CNC Homology 1 and 2 (Bach1/Bach2) factors belong to 
the basic region leucine zipper (bZIP) family of transcription factors (Oyake et al., 1996). 
As members of the bZIP family, Bach1 and Bach2 exert regulatory influence over target 
Maf recognition elements (MAREs) by dimerically binding TGA(G/C)TCA motifs via 
their conserved leucine zipper domains (Igarashi, Kurosaki, & Roychoudhuri, 2017; 
Reinke, Baek, Ashenberg, & Keating, 2013). From a structural standpoint, the Bach 
proteins share an N-terminus broad-complex, tramtrack and bric-à-brac (BTB) domain, 
though Bach2 alone possesses an intrinsically disordered region, located between its bZIP 
and BTB domains (Igarashi et al., 2017). Bach2 has further been shown capable of 
interacting with target sequences as a homodimer, while Bach1 must heterodimerize with 
proteins of the MAF family to bind DNA (Oyake et al., 1996). Since their identification, 
and despite these modest structural differences, the Bach factors have primarily been 
characterized as transcriptional repressors (Oyake et al., 1996). Within the immune 
compartment, Bach1 is highly expressed in myeloid-lineage cells, while Bach2 exhibits 
lymphoid-restricted expression patterns (Heng, Painter, & Consortium, 2008). 
In recent years, a number of reports have implicated Bach2 in the regulation of early B cell 
development, and cellular fate decisions during immune responses (Kometani et al., 2013; 
Sidwell & Kallies, 2016; Ye & Mai, 2013). Mice lacking both Bach factors harbour marked 
defects in B lymphopoiesis, and exhibit increased myelopoiesis (Itoh-Nakadai et al., 2014). 
These defects have been partly attributed to loss of Bach2-mediated repression of myeloid-
associated genes, such as Cebpb and Ly96, along with Spic (Itoh-Nakadai et al., 2014). 
Early reports have demonstrated that Bach2 expression in early B cell precursors allows 
repression of premature Ig heavy chain transcription during development (Muto et al., 
1998). In pre-B cells, Bach2 critically opposes the action of Bcl6 during negative 
selection—with Bach2 expression enabling the removal of pre-B cells bearing non-
productive heavy chain rearrangements (Swaminathan et al., 2013).  
Following B cell maturation and activation, Bach2 has been shown to play an important 
role in the processes of CSR and SHM (Muto et al., 2004). Upon T cell-dependent 
immunization, Bach2-/- mice lacked GCs, exhibited impaired class-switching to IgG1 and a 
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minimal high affinity-conferring mutations in CDRs (Muto et al., 2004). The lack of GC 
establishment was linked, in a later report, to accelerated differentiation of Bach2-/- splenic 
B cells into IgM-producing PCs, due to loss of Bach2-mediated repression of Prdm1 (Muto 
et al., 2010; Ochiai et al., 2006). In vitro studies have suggested that synergistic co-
repression of Blimp-1 by Bach2 and Bcl6, potentially driven by direct interactions between 
the factors, plays an important role in maintaining the identity of activated B cells (Ochiai, 
Muto, Tanaka, Takahashi, & Igarashi, 2008). 
 In addition to delaying plasma cell differentiation, allowing sufficient time for GC B cells 
to undergo CSR and SHM, Bach2 has been implicated in the generation of immunological 
memory in B and T cells (Roychoudhuri et al., 2016; Shinnakasu et al., 2016). Loss of 
Bach2 was shown to lead to reductions in the memory B cell pool, independently of Blimp-
1 transcriptional repression (Shinnakasu et al., 2016). High levels of Bach2 expression in 
GC B cells, likely the result of relatively weak T cell help, has been posited to promote 
their differentiation into MBCs (Shinnakasu et al., 2016). These findings suggest that 
Bach2 constitutes a key regulator in the affinity-based model of activated B cell fate 
decisions—a model in which high-affinity cells are predisposed to enter the PC 
compartment, while cells of lesser affinity have an increased probability of differentiating 
into MBCs (Phan et al., 2006). 
1.6 Hypothesis & Specific Aims 
The governing hypothesis underlying the present study is that Spi-C opposes the function 
of related Ets transcription factors PU.1 and Spi-B during B cell antibody-forming 
responses to T cell-dependent antigens. As such, and based on available literature 
suggesting a negative regulatory role for Spi-B in PC differentiation, we specifically 
hypothesize that: 
I. The impaired secondary IgG1, IgG2a/c and IgG2b responses observed by Su et al. in 
Spib-/- mice will be rescued in Spib-/- Spic+/- mice (Su et al., 1997). 
II. The defects in secondary responses exhibited by Spib-/- animals stem from an 
increased propensity of B cells for premature differentiation into PCs, at the 
putative expense of MBCs. We predict that Spi-C heterozygosity on a Spib-/- 
background will result in decreased PC generation, compared to Spib-/- B cells. 
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III. Loss of Spi-B alters the transcriptional profile of activated B cells, predisposing 
them to take on a PC phenotype, while concurrent loss of Spi-C will promote the 
maintenance of B cell identity.  
In keeping with the specific hypotheses outlined above, the following research aims are 
proposed: 
i. To characterize the impact of Spi-C heterozygosity on antibody-forming 
responses, following immunization with T cell-dependent model antigen NP-
OVA in Spib-/- mice. 
ii. To investigate the respective capacities of Spib-/- and Spib-/- Spic+/- B cells to 
differentiate into CD138+ antibody-secreting cells (ASCs), under ex vivo 
conditions which promote PC differentiation. 
iii. To identify a candidate gene for joint regulation by Spi-B and Spi-C, which has 
been implicated in the fate determination of activated B cells. 
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2 Chapter 2: Methods 
2.1 Mice 
Spib-/- and Spib-/-Spic+/- mice were generated as previously described (Li et al., 2015). 
C57BL/6 (WT) mice were purchased from Charles River Laboratories (Pointe-Claire, QC, 
Canada). All animals were housed under specific pathogen-free conditions at the West 
Valley facility (London, ON), and were monitored in accordance with an animal use 
protocol approved by the Western University Council on Animal Care. Genotyping was 
performed by PCR, as previously described, using the primers outlined in Table 1 (DeKoter 
et al., 2010; Kohyama et al., 2009). 
2.2 Cell culture 
Mouse 39B9 pre-B cells were cultured in RPMI-1640 medium (Wisent, St-Bruno, Qc, 
Canada) supplemented with 10% bovine serum, 5 mg/mL penicillin/streptomycin/L-
glutamine, and 5 x 10-5 M β-mercaptoethanol (βME). Primary B cells were cultured in 
complete RPMI-1640, requiring 10% fetal bovine serum, 5 x 10-5 M βME, 0.01 M HEPES, 
10 units penicillin/1 mg/mL streptomycin/20 mM L-glutamine, 10 mM sodium pyruvate, 
1 mM MEM non-essential amino acids (ThermoFisher Scientific, Rochester, NY). Cells 
were cultured under the following conditions: 37°C at 5% CO2. 
2.3 T cell-dependent immunizations 
Six to eight week-old mice were immunized intraperitoneally with 100 ug of NP15-OVA 
or NP17-OVA (Biosearch Technologies, Novato, CA) adjuvanted with 50% (vol/vol) of 
Imject™ alum (ThermoFisher Scientific, Rochester, NY). For experiments involving 
secondary responses, mice were re-immunized on day 30 following the primary challenge 
with a boosting dose identical to that of the prime. 
2.4 ELISpot assay 
Frequencies of NP-specific antibody-secreting cells (ASCs) per 106 splenocytes were 
determined using the ELISpot assay on Immunolon Microtiter 4 HBX plates 
(ThermoFisher Scientific, Rochester, NY). Following spleen excision, single cell-
suspensions were obtained using frosted glass slides and filtered through a fine nylon mesh 
 
 
 30 
(Component Supply Company, Sparta, TN) Splenocytes were red blood cell (RBC)-
depleted by ammonium-chloride-potassium (ACK) lysis, washed in MACS buffer (10% 
fraction V fetal bovine serum (FBS), 5% EDTA in PBS) and counted using the Moxi Z 
Mini Automated Cell Counter (Orflo, Ketchum, ID). Splenocytes were serially diluted in 
triplicate from a starting concentration of 1 x 106 cells per 300 µl, and incubated in NP-
KLH-coated wells (Biosearch Technologies, Novato, CA) for 5 hours at 37°C (5% CO2) 
in 10% FBS-containing RPMI 1640. Alkaline phosphatase (AP)-conjugated goat anti-
mouse IgM (1:1500) (Mabtech AB, Sweden), IgG1, IgG2b and IgG2c (1:2500) (Jackson 
Immunoresearch, Westgrove, PA) were incubated overnight in corresponding wells. The 
5-bromo-4-chloro-3-indolyl-phosphate (BCIP, Sigma-Aldrich, St. Louis, MO) substrate in 
3% low-melt agarose gel (NuSieve™ GTG Agarose, Lonza), diluted in Tris/NaCl solution 
(Tris 100 mM, NaCl 100 mM, MgCl2 5 mM, pH 9.5), were used to develop spots. Plates 
were imaged using the ImmunoSpot® S6 Analyzer, and counted using the ImmunoSpot® 
software (Cellular Technology Limited (CTL), Cleveland, OH). Spot counts from triplicate 
wells in individual mice were averaged, then plotted against the corresponding dilution for 
each antibody. Logarithmic regressions were performed in Excel using built-in functions, 
and curves of best fit were used to calculate adjusted frequencies of ASCs per 1 x 106 cells. 
2.5 Flow cytometry 
Following spleen excision, single cell-suspensions were obtained using frosted glass slides 
and filtered through a fine nylon mesh (Component Supply Company, Sparta, TN). 
Samples were RBC-depleted by ammonium-chloride-potassium (ACK) lysis, then washed 
in MACS buffer and counted using the Moxi Z Mini Automated Cell Counter (Orflo, 
Ketchum, ID). Anti-Fc-γ receptor blocking was performed using purified purified rat anti-
mouse CD16/CD32 (BD Bioscience, Franklin Lakes, NJ). Cell-surface staining was 
performed using the following antibodies at a concentration of 1:100 in MACS buffer, 
purchased from eBioscience (San Diego, CA), BD Bioscience (Franklin Lakes, NJ) or 
Biolegend (San Diego, CA): Brilliant Violet 421- and allophycocyanin-conjugated anti-
CD45R/B220 (Ra3-6B2), biotin- and phycoerythrin (PE)-conjugated anti-CD138 (281-2), 
PE- and fluorescein (FITC)-conjugated CD19 (6D5), and PE-conjugated streptavidin. 
Live/dead staining was performed using the Fixable Viability Dye eFluor 506 
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(eBioscience, San Diego, CA) according to manufacturer’s instructions. Samples were run 
at the London Regional Flow Cytometry Facility on a FACSCanto SORP (BD 
Biosciences), and acquired using FACSDiva (Version 8.0.1). Analysis was performed 
using the FlowJo software (TreeStar, Ashland, OR) (Version 10.4.2).  
2.6 B cell enrichment & ex vivo plasma cell generation assay 
Spleens were harvested from male mice aged 6-10 weeks and gently ground into a single-
cell suspension using frosted glass slides, as described above. Following RBC depletion by 
hypotonic lysis, B cells were enriched by negative selection using the Miltenyi system—
comprised of the VarioMACS magnet, LD depletion columns, streptavidin microbeads 
(Miltenyi Biotec, Germany) and biotin-conjugated mouse anti-CD43 (clone: S7). 
Following enrichment, B cells were stained using the CellTrace Violet Cell Proliferation 
Kit (ThermoFisher Scientific, Rochester, NY) at a concentration of 1.5 µM. Enriched, 
CellTrace-stained B cells were plated (1 x 105 / well) in 96-well plates under modest 
(recombinant murine IL-4 and CD40L (1:1000), R&D Systems, Minneapolis, NE), potent 
(recombinant murine IL-4, IL-5 and CD40L (1:1000), R&D Systems, Minneapolis, NE) or 
no stimulation conditions in complete RPMI-1640. At days 4 and 5 of culture, the cells 
were stained using PE-conjugated anti-CD138 and APC-conjugated B220 (1:100) along 
with Fixable Viability Dye eFluor 506 (eBioscience, San Diego, CA) and assessed on the 
BD FACS Canto (BD Biosciences, San Jose, CA, USA) instrument at the London Regional 
Flow Cytometry Facility. 
2.7 Reverse transcription quantitative polymerase chain reaction 
(RT-qPCR) 
Total RNA was extracted from fresh or cultured primary B cells using the TRIzol method 
(ThermoFisher Scientific, Rochester, NY). cDNA synthesis (iScript cDNA Synthesis Kit, 
Bio-Rad, Mississauga, ON) was performed using equal starting RNA concentrations, 
followed by RT-qPCR analysis, which was conducted using the SensiFAST SYBR No-
ROX Kit (Bioline, Singapore) on the QuantStudio 5 Real-Time PCR System 
(ThermoFisher Scientific, Rochester, NY).  
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Table 1. Primer sequences used for genotyping. 
  
Primer Name 
 
Sequence (5’ – 3’) 
 
Source 
 
Spib KO fwd GGG CTC CTT GGC TTA TGC TCC 
 
rev CAG AAA GCG AAG GAG CAA AGC TG 
Spib WT fwd GGG CTC CTT GGC TTA TGC TCC 
rev CGC GCT GTC AAA CTG GTA GGT 
Spic KO fwd AAG CTT GGC TGG ACG TAA ACT CCT 
(Kohyama et al., 2009) 
rev AGA ACC AAG ACT ACC AGC CCA GAT 
Spic WT CGG CAG ACA CTT TGC TAT TTC 
rev CCT CAA CTG AAG CTC CTT TCT 
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Analyses were conducted in duplicates, with relative expression of target genes normalized 
to that of Tata-binding protein (Tbp), and calculated as fold change using the comparative 
threshold cycle (2-∆∆CT) method (Pfaffl, 2004). The selection of Tbp as a reference gene 
was carried out, on the basis of its relative stability and high expression, by re-analysis of 
previously published RNA-seq data (GEO accession code: GSE60927) (Shi et al., 2015), 
in which the variance in log2FPKM values from sorted FO B cells, GC B cells, plasmablast 
and PC subsets was compared. Amplification efficiencies were calculated for each primer 
pair (Table 2) using calibration curves generated by triplicate doubling dilutions of total 
splenocyte cDNA. Primer pairs with efficiencies ranging from 90-110% were used in the 
study. 
2.8 Production of retrovirus 
MIG-3XFLAG-SpiB and MIG-3XFLAG-SpiC plasmids (herein referred to as MIG-SpiB 
and MIG-SpiC, respectively) were generated as previously described (Xu et al., 2012). 
Production of retroviral particles was achieved by the transfection of Platinum-E (Plat-E) 
retroviral packaging cells with MIGR1, MIG-SpiB and MIG-SpiC plasmids using 
polyethyleminine (PEIpro, PolyPlus, Illkirch, France) (Morita, Kojima, & Kitamura, 
2000). Plat-E supernatant containing viral particles was harvested after 48 hours, and 
transfection efficiency (GFP expression)  was analyzed by flow cytometry. 
2.9 Primary B cell transduction 
Primary B cells were enriched from total splenocytes as above and stimulated in IL-4+IL-
5+CD40L (R&D Systems, Minneapolis, NE) overnight. Transduction of stimulated, 
enriched B cells was performed by centrifugal infection at 2000 x g for 3 hours at 32 °C. 
Following transduction, primary B cells were cultured for 3 days in complete RPMI 
(Wisent, St-Bruno, Qc, Canada) containing IL-4+IL-5+CD40L (R&D Systems, 
Minneapolis, NE), as described above. 
2.10 Chromatin immunoprecipitation 
Chromatin was prepared from pellets of 1 x 106 transduced, potently stimulated B cells as 
described in (DeKoter et al., 2010). Protein-DNA cross-linking was performed using 1% 
formaldehyde (MilliporeSigma, Darmstadt, Germany) and halted using glycine (1.25 M). 
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Pellets were flash-frozen in liquid nitrogen prior to sonication. Thawed pellets were lysed 
in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris) supplemented with Halt Protease 
Inhibitor (ThermoFisher Scientific, Rochester, NY), prior to sonication for 25 cycles using 
the Bioruptor UCD-300 water bath sonicator (Diagenode, Sparta, NJ). 
Immunoprecipitation of FLAG-bound chromatin was performed using anti-FLAG 
antibodies conjugated to magnetic beads, washed with 0.1% PBS-T (MilliporeSigma, 
Darmstadt, Germany). Bead-bound chromatin was washed sequentially with Wash Buffer 
I (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris, 150 mM NaCl), Wash Buffer II (0.1% 
SDS, 1% Triton, 2 mM EDTA, 20 mM Tris, 500 mM NaCl), Wash Buffer III (0.25 M 
LiCl, 1% NP40, 1 mM EDTA, 20 mM Tris (pH = 8.0), 1% deoxycholate) and Tris-EDTA 
buffer. DNA was eluted in elution buffer, and purified using QIAquick PCR Purification 
Kit (Qiagen, Hilden, Germany). qPCR on purified DNA was performed as described 
above, using primers targeting regions of interest (ROIs) and outlined in Table 2. Threshold 
cycle values were used to calculate percent input. ROIs were identified by analysis of 
published ChIP-seq data (GEO accession code: GSE58128) (Solomon et al., 2015). The 
sequence of the Bach2 locus was submitted for multi-species conservation analysis 
(PhastCons46wayPlacental) to ORCAtk (Version 1.0.0), with the following settings: 
minimum conservation – 70%, minimum conserved region – 20. Motif discovery within 
ROIs was performed using the MEME Suite, version 4.12.0 (Bailey & Elkan, 1994).  
2.11 Statistical analyses 
Statistical analyses were performed using Prism 6.0 (GrapPad, La Jolla, CA). Unless 
otherwise indicated, the data presented herein was analyzed by one-way ANOVA, with 
Tukey’s multiple comparisons test and p < 0.05 denoting significance. 
  
 
 
 35 
 
Table 2. Primer sequences used for qPCR analysis 
  
Primer Name 
 
Sequence (5’ – 3’) 
 
Source 
 
Bach2 CAT CTC TTC CTC TGC CCA GT 
(Kometani et al., 2013) 
rev AGA CAT GCC GTT CAA ACC AT 
Bcl6 fwd CCT GTG AAA TCT GTG GCA CTC G (Raczkowski et al., 
2013) rev CGC AGT TGG CTT TTG TGA CG 
IRF4 fwd GAA AAT GGT TGC CAG GTG ACA G 
 
rev GCT TCA GCA GAC CTT ATG CTT G 
Pax5 TCG GAC CAT CAG GAC AGG ACA 
 
rev GTT CCA CTA TCC TTT GGC GGA 
Prdm1 fwd ACA TAG TGA ACG ACC ACC CCT G 
(Harada et al., 2012) 
rev CTT ACC ACG CCA ATA ACC TCT TTG 
Tpb fwd ACC GTG AAT CTT GGC TGT AAA C 
(Eissa et al., 2016) 
rev GCA GCA AAT CGC TTG GGA TTA 
ChIP ROI 1 fwd GTG GTC GAT AGG GCA GCT ATT T 
 
rev CAA CTC ACT CTC CGT GTT TCA 
ChIP ROI 3 fwd CGT AAG GCA GAG ATC CGA AGT 
 
rev CTT CCT TAC TGA GAA CTC CCT GG 
ChIP NCR fwd ATA ACT ACT GTG GAT GCC CTC AC  
 rev 
 
CAG GCT TTA GAC GAT GCC TGA TA 
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3 Chapter 3: Results 
3.1 Loss of Spi-C rescues Spib-/- defect in secondary T cell-
dependent B cell responses 
Mice harbouring a germline deletion of Spi-B on a BALB/c background have previously 
been reported to elicit reduced titers of IgG1, IgG2a and IgG2b antibody isotypes in response 
to secondary challenge with haptenated model antigen keyhole limpet hemocyanin (Su et 
al., 1997). We sought to determine whether impairments in Spib-/- antibody-secreting cell 
(ASCs) frequencies could be observed in a similar model of secondary T cell-dependent 
immunization (Su et al., 1997). Spib-/-, Spib-/-Spic+/- and C57BL/6 (WT) mice were 
immunized intraperitoneally with a priming dose of 4-hydroxy-3-nitrophenylacetyl (NP) 
haptenated-ovalbumin (NP-OVA) precipitated in alum at day 0. An identical challenge was 
administered at day 30 post-immunization, and splenic frequencies of ASCs were assessed 
in both immunized and naïve mice by Enzyme-Linked ImmunoSpot (ELISpot) at day 37 
post-immunization. For sex-matched Spib-/- and Spib-/-Spic+/- immunized litter mates, we 
observed a general dominance of IgG1 responses over IgM, which was expected based on 
the immunization strategy (Fig. 3-1A) (Xu et al., 2015). We additionally noted a moderate 
decrease in the frequencies of Spib-/- IgG1, but not IgM, ASCs relative to WT mice (Fig. 3-
1A). In agreement with earlier reports, loss of Spi-B corresponded to a significant reduction 
in frequencies of NP-reactive, IgG1-forming ASCs in immunized Spib-/- mice, relative to 
those observed in NP-sensitized WT controls (Fig. 3-1B, 3-1C). By contrast, IgG1 ASC 
frequencies in Spib-/-Spic+/- mice were rescued to that of WT levels (Fig. 3-1B, 3-1C). 
ELISpot analysis of IgM, IgG2b and IgG2c isotypes revealed normal frequencies of NP-
specific ASCs in Spib-/- and Spib-/-Spic+/- mice, relative to their WT counterparts (Fig. 3-
1D, 3-1E, 3-1F). No difference was detected with regards to the size (µm²) of IgG1 and 
IgM spots across the genotypes of interest (data not shown). These results raise the 
possibility that Spib-/- mice present with a defect in secondary responses. Moreover, rescue 
of secondary Spib-/- IgG1 ASC frequencies by heterozygous loss of Spi-C suggests an 
opposing role for Spi-C in regulating antibody-forming responses.  
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Figure 3-1. Frequencies of secondary NP-specific IgG1-ASCs per 106 splenocytes in 
immunized Spib-/- mice are decreased relative to WT mice, and rescued in Spib-/-Spic+/- 
animals at 37 d.p.i. (A) ASC frequencies per 106 splenocytes obtained from one 
representative male cohort. Black bars represent IgG1, while grey bars represent IgM, with 
each bar representing a single mouse. ‘0’ denotes an absence of spots. Data points were 
calculated from logarithmic functions, obtained by plotting mean values of spots from 
triplicate wells against corresponding dilutions for each mouse. (B) IgG1-ASC frequencies 
across immunized male and female cohorts. Horizontal bars represent mean ± SEM, n=10 
for Spib-/- and Spib-/-Spic+/- mice, n=7 for WT mice. Data points were calculated as in (A). 
(C) Representative ELISpot wells for IgG1 and IgM detection, from the single male cohort 
shown in (A). Representative IgG2b and IgG2c wells. (D) IgM-ASC frequencies across 
immunized male and female cohorts. Horizontal bars represent mean ± SEM, n=9 for Spib-
/- and Spib-/- Spic+/- mice, n=7 for WT mice. Data points were calculated as in (A). (E, F) 
IgG2b- and IgG2c-ASCs frequencies across immunized male and female cohorts. Horizontal 
bars represent ± SEM, n=5 for Spib-/- and Spib-/- Spic+/- mice, n=3 for WT mice. Data points 
were calculated as in (A). *p < 0.05, ns = non-significant, as per one-way ANOVA (two-
tailed). 
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Based on previous reports that Spib-/- mice are capable of generating GCs which are poorly 
sustained at 28 days, we sought preliminary evidence that Spi-C heterozygosity might 
rescue the maintenance defect in Spib-/- GCs (Su et al., 1997). As per the ELISpot assay 
outlined above, Spib-/-, Spib-/-Spic+/- and WT mice were immunized by i.p. injection with a 
priming dose of NP-OVA, then re-challenged after 30 days. At day 37 post-immunization, 
spleens were harvested and flow cytometric analysis was performed to characterize the 
frequencies of splenic CD19+CD138-CD95hiCD38lo GC cells across our three genotypes 
of interest (Fig. 3-2A). Samples were first gated on the live CD4-CD19+CD138- population 
to exclude non-B lymphocytes and PCs from the analysis, and subsequently gated on GC 
B cells, which express high levels of cell-surface CD95 (Fas), and low levels CD38 (Hao 
et al., 2008; Oliver, Martin, & Kearney, 1997) (Fig. 3-2B). Despite n values too low to 
permit statistical analysis, we observed a trend towards reduced frequencies of 
CD95hiCD38lo cells in Spib-/- spleens, relative to that of the WT mouse—a reduction that 
was seemingly rescued in the Spib-/-Spic+/- mice (Fig. 3-2C). These results suggest that 
secondary GCs may be impaired in Spib-/- mice. 
3.2 Spib-/- and Spib-/-Spic+/- spleens harbour normal primary 
frequencies of IgG1-secreting cells relative to WT spleens 
We have previously characterized a decrease in both the frequencies and absolute numbers 
of splenic follicular (FO) B cells in Spib-/- mice, relative to both WT and Spib-/-Spic+/- 
animals (Li et al., 2015). To determine whether the observed impairment in the dominant 
IgG1-forming secondary responses of Spib-/- mice stem from diminished ‘steady-state’ 
frequencies of splenic FO B cells, we immunized Spib-/-, Spib-/-Spic+/- and WT mice using 
NP-OVA in alum, and assessed ASC frequencies at day 7 post-immunization. At this 
timepoint, we aimed to investigate a potential defect in ASC frequencies in the early stages 
of the primary response. In accordance with previous reports (Su et al., 1996; Willis et al., 
2017), we observed normal primary frequencies of NP-reactive ASCs in responding Spib-
/- and Spib-/-Spic+/- animals, across assayed IgG1, IgM, IgG2b and IgG2c isotypes (Fig 3A-
D). Spib-/- spleens consistently exhibited comparable frequencies of responding ASCs to 
those of WT controls, despite a previously noted reduction of Spib-/- FO B cells in the 
absence of immunization (Fig. 3-3A-D) (Li et al., 2015).   
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Figure 3-2. Loss of Spi-C on a Spib-/- background may rescue defects in secondary 
germinal centers formation or maintenance. (A) WT, Spib-/- and Spib-/- Spic+/- mice were 
immunized with NP-OVA in alum at day 0, boosted on day 30 and sacrificed on day 37 
for analysis. (B) Flow cytometry plots depicting frequencies of CD95hiCD38lo cells in Spib-
/- and Spib-/- Spic+/- mice at the 37 days post-immunization timepoint. Samples were 
initially gated on live cells using a live/dead stain, while lymphocyte and singlet 
populations were identified based on light scatter properties. Subsequent gating on 
CD19+CD138- and CD4- fractions was used to remove PCs and Tfh cells from the analysis. 
(C) Quantitation of CD95hiCD38lo cells frequencies across WT, Spib-/- and Spib-/- Spic+/- 
genotypes. Bars represent group means ± SEM, n=2 (Spib-/- and Spib-/-Spic+/-) and n=1 
(WT). 
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Figure 3-3. ASC frequencies from Spib-/- spleens are comparable to that of Spib-/-
Spic+/- and WT animals at 7 d.p.i. (A) Frequencies of IgG1-forming ASCs per 106 
splenocytes across immunized male WT (n = 7), Spib-/- R (Responders) and Spib-/-Spic+/- 
(n = 8), along with Spib-/- NR (Non-Responders) (n = 5) = mice. Horizontal bars represent 
mean ± SEM. Data points were calculated from logarithmic functions, obtained by plotting 
mean values of spots from triplicate wells against corresponding dilutions for each mouse. 
(B) IgM-ASC frequencies across immunized and non-immunized males cohorts as in (A). 
(C, D) IgG2b- and IgG2c-ASCs frequencies across immunized mice, n = 8. (E) ASC 
frequencies per 106 splenocytes obtained from WT, responder and non-responder Spib-/- 
and Spib-/-Spic+/- mice. White bars represent IgG1, while black bars represent IgM. 
Horizontal bars represent ± SEM, data points were calculated as in (A). Statistics performed 
using one-way ANOVA (two-tailed). (F) ELISpot wells for IgG1, IgM, IgG2b and IgG2c 
detection from one representative cohort, showing immunized mice.  
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Within immunized Spib-/- animals, we additionally noted a population of non-responder 
(NR) mice, which failed to respond to the i.p. immunization protocol. NR mice comprised 
35.7% of the immunized Spib-/- animals, and yielded no detectable class-switched ASCs, 
along with IgM ASC frequencies comparable to that of those from non-immunized mice 
(Fig. 3-3E). Taken together, these findings suggest that Spib-/- mice manifest a defect in 
secondary responses to T cell-dependent immunization, which is rescued by heterozygous 
loss of Spi-C. 
3.3 Increased ASC differentiation in Spib-/- and Spib-/- Spic+/- B 
cells ex vivo, relative to WT B cells 
Multiple reports have described a redundant role for PU.1 and Spi-B in opposing plasma 
cell differentiation (Carotta et al., 2014; Schmidlin et al., 2008; Willis et al., 2017; Xu et 
al., 2015). Based on our observation that Spi-C heterozygosity rescues the impairment of 
memory responses in Spib-/- mice, we hypothesized that Spi-C might act as a cell intrinsic 
positive regulator of the plasma cell fate decision. To assess the respective capacities of 
Spib-/- and Spib-/-Spic+/- B cells to terminally differentiate into CD138-expressing plasma 
cells (PC), spleen-derived enriched B cells (~97%) (Fig. 3-4A) were stimulated under 
modest or potent stimulation conditions, in the presence of CD40L and IL-4, or in media 
containing a combination of CD40L, IL-4 and IL-5, respectively. Naïve enriched B cells 
were stained with CellTrace Violet (CTV) and cultured for a period of 5 days. Extensive 
proliferation of B cells was observed at day 4 of cultures (Fig. 3-5). The day 5 timepoint 
was selected on the basis of maximized CD138 expression in samples stimulated for 5 
days, relative to enriched B cell cultures of 3 and 4 days (Fig. 3-6A). Flow cytometric 
analysis was performed to assess the proliferation and differentiation status of stimulated 
WT, Spib-/- and Spib-/-Spic+/- B cells. Upon exposure to CD40L and IL-4, WT, Spib-/- and 
Spib-/-Spic+/- enriched B cells differentiated into CD138+ cells to a similar extent over the 
course of 5 days (data not shown). However, frequencies of CD138-expressing cells in 
both Spib-/- and Spib-/-Spic+/- samples were significantly elevated upon addition of IL-5, as 
compared to WT samples (Fig. 3-6B).  
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Figure 3-4. B cell enrichment and PC depletion approaches. (A) Mature resting B cells 
were enriched from whole WT spleens using biotinylated anti-CD43 antibodies, Miltenyi 
streptavidin microbeads and magnetic columns. Pre-enrichment and post-enrichment 
samples are shown, stained for cell-surface CD19 and B220. Samples were initially gated 
on single cells using light scatter properties, as shown in the reduced ‘gating’ panels. (B) 
Following CD43-based B cell enrichment, samples were stimulated for four days using 
CD40L, IL-4 and IL-5, and subjected to CD138-based depletion using the Miltenyi system. 
Samples were initially gated on single cells as above, and stained for CD138 and B220 
expression. 
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Figure 3-5. Phase-contrast micrographs of enriched B cells stimulated using IL-4, IL-
5 and CD40L for four days. Splenocytes from WT, Spib-/- and Spib-/- Spic+/- mice were 
harvested on day 0 and enriched for mature resting B cells by means of CD43 negative 
selection. Following CellTrace staining, enriched B cells were placed in culture under the 
following condition: modest stimulation (IL-4+CD40L), potent stimulation (IL-
4+CD40L+IL-5) and no stimulation (RPMI only). Images were taken at 20X 
magnification, using the Zeiss AxioObserver A1 and AxioCam ICM1. Scale bars represent 
50 µm. 
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Figure 3-6. Spib-/- enriched B cells undergo accelerated terminal differentiation 
relative to WT enriched B cells when stimulated with CD40L+IL-4+IL-5 (A) Overlaid 
histograms of representative samples showing CD138 positivity in WT enriched B cells 
cultured over the course of three (light grey), four (dark grey) or five (black) days in the 
presence of CD40L, IL-4 and IL-5. Samples were initially gated on live, single cells using 
light scatter properties. CD138 staining is shown on the x-axis. (B) Total frequencies of 
plasma cells (CD138+) cells across WT, Spib-/- and Spib-/-Spic+/- samples following potent 
stimulation at day 5 post-enrichment. Group means are shown ± SEM. **p < 0.01, as per 
one-way repeated measures ANOVA (two-tailed). (C) Frequencies of plasma cells 
(CD138+; upper horizontal gate) were quantified in WT, Spib-/- and Spib-/-Spic+/- enriched 
B cells, following stimulation for 5 days under modest (CD40L+IL-4) or potent stimulation 
(CD40L+IL-4+IL-5) conditions. Cells were pre-gated based on light scatter, and the ‘live’ 
population was identified by use of a live/dead stain. To control for differential staining 
with CellTrace Violet across samples, cells were assigned to vertical gates representing 
‘generations’. The rightmost gate denotes generation 1. Data shown are representative of 
seven trials, with an n = 1 for each genotype per trial. (D) Frequencies of plasma cells 
(CD138+B220lo) and undifferentiated (CD138-B220hi) cells were quantified for each 
generation in WT, Spib-/- and Spib-/-Spic+/- enriched B cells, following stimulation for 5 
days under modest (CD40L+IL-4) or potent stimulation (CD40L+IL-4+IL-5). Black bars 
represent undifferentiated cell frequencies, while white bars represent differentiated cell 
frequencies across seven independent trials. Group means are represented ± SEM, with 
uppermost error bars removed for clarity. * p < 0.05, § p < 0.05, ** p < 0.01, as per two-
way repeated measures ANOVA.  
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To explore the kinetics of differentiation in successive rounds of CTV-labelled cellular 
divisions, samples were gated on CD138-expressing cells within individual generations 
(Fig. 3-6C). The use of an arbitrary generation-based analysis revealed a significant 
increase in the proportion of Spib-/- CD138+ cells within the third round of cell division, 
relative to that of modestly stimulated WT samples (Fig. 3-6D). Upon culture in IL-4, 
CD40L and IL-5 supplemented media, we likewise noted a marked increase in the 
proportion of Spib-/- CD138+ as early as the third generation, compared to WT enriched B 
cell samples (Fig. 3-6D). The increase in the Spib-/- CD138+ compartment became more 
pronounced in generations 4 and 5, and was eventually lost in subsequent generations (Fig. 
3-6D). By contrast, Spib-/-Spic+/- subsets exhibited a seemingly intermediate phenotype 
within both stimulation conditions (Fig. 3-6D). When stimulated using CD40L and IL-4, 
Spib-/-Spic+/- showed no difference across generations when compared to either Spib-/- or 
WT samples (Fig. 3-6D). Spib-/-Spic+/- samples showed an increase in the proportion of 
CD138+ PCs in generation five alone, relative to the WT, when cultured in the presence of 
IL-4, CD40L and IL-5 (Fig. 3-6D). These results highlight the accelerated differentiation 
of Spib-/- enriched B cells into CD138-expressing PCs upon stimulation with CD40L, IL-4 
and IL-5, which can partially be hampered by the concomitant loss of one functional Spi-
C allele. 
3.4 Loss of Spi-B corresponds to decreased Bach2 expression in 
potently stimulated enriched B cells 
To investigate the mechanistic underpinnings of restrained PC differentiation in Spib-/-
Spic+/- enriched B cells, we sought to characterize the changes in gene expression incurred 
by B cells upon stimulation across our genotypes of interest. As above, B cells were 
enriched using CD43-based magnetic bead depletion and cultured for four days under 
potent stimulation conditions (Fig. 3-4A). On the fourth day of stimulation, stimulated B 
cells from WT, Spib-/- and Spib-/-Spic+/- mice were positively or negatively selected on the 
basis of CD138 expression using magnetic beads (Fig. 3-4B). Total RNA was obtained 
from CD138-enriched or –depleted fractions and used to interrogate the expression of 
Blimp-1 (encoded by Prdm1), Pax5, Bach2, Bcl6, and IRF4 by reverse transcriptase 
quantitative PCR (RT-qPCR).   
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Gene Mean Log2FKPM Variance 
FO B cells GC B cells Plasmablasts Plasma cells 
Actb 11.3643369 11.9691542 8.821832 8.68619092 2.470726185 
B2m 11.3655073 9.01972367 13.1077274 12.8097644 2.911501739 
Gapdh 2.68762562 2.91673168 2.83524299 4.28677542 0.310613562 
Tbp 4.61012514 4.42165738 4.27496641 4.0909371 0.053256973 
Ubc 5.43640604 4.85325435 5.47507066 5.663826 2.079389762 
 
Table 3. Selected candidate reference genes 
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Selection of an appropriate reference gene was carried out by re-analysis of RNA-seq data 
sets originally published and made publicly available by Shi and colleagues (Shi et al., 
2015). These sets contained gene expression data from sorted follicular (n = 2) and GC B 
cells (n = 2), along with sorted plasmablasts (PBs, n = 1) and PCs (n = 3), expressed as log-
transformed fragments per kilobase of transcript per million mapped reads (log2FPKM). 
The variance (σ2) of log2FPKM values for each gene were calculated across the sorted cell 
subsets, using the equation σ2 = (∑ (X - µ)2/ n, wherein X denotes individual data point, µ 
represents the mean log2FPKM for each gene and n signifies the total number of subsets 
and their replicates (n = 8). We narrowed our analysis to genes commonly used or 
previously identified in the literature as reference in leukocyte gene expression analyses—
such as the genes encoding glyceraldehyde-3-phosphate dehydrogenase (Gapdh), β-actin 
(Actb), β-2 microglobulin (B2m), ubiquitin C (Ubc), and TATA-binding protein (Tbp) 
(Mosley & Hogenesch, 2017; Zhang, Ding, & Sandford, 2005). Within this narrow gene 
list, Ubc, Actb and B2m exhibited the largest variance in expression, with σ2 values of 2.08, 
2.47 and 2.911, respectively (Table 3). While Gapdh expression fluctuated substantially 
less than that of the common housekeeping gene Actb, Tbp expression varied least during 
the fate differentiation event from mature B cell to plasma cell, with an σ2 of 0.05 (Table 
3). These results suggest that Tbp might be a suitable reference gene following stimulation 
of ex vivo primary B cells. 
Following inter-sample normalization to Tbp transcripts, we found mRNA transcript levels 
of Prdm1 to be significantly elevated across WT, Spib-/- and Spib-/-Spic+/- CD138-enriched 
samples, relative to that of the WT CD138-depleted fraction, as would be expected based 
on the differentiation of B cells into plasma cells (Fig. 3-7A). Levels of Pax5 were 
significantly decreased in both Spib-/- and Spib-/-Spic+/- CD138+ samples, relative that of 
WT CD138- samples (Fig. 3-7B). The marked decrease in Pax5 expression in Spib-/- and 
Spib-/-Spic+/- PCs suggests a more pronounced, or rapid loss of B cell identity than that 
which occurs within the WT CD138+ subsets (Fig. 3-7B). With regards to Bach2 
expression, levels of Bach2 transcript were significantly downregulated in Spib-/- CD138+ 
samples, but not in corresponding WT or Spib-/-Spic+/- CD138-expressing subsets (Fig. 3-
7C).  
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Figure 3-7. Loss of Spi-B or Spi-C on Spib-/- background alters the expression of genes 
which direct the maintenance of B cell, GC B cell and PC identities. (A-E) RT-qPCR 
analysis was performed for the indicated genes using whole RNA prepared from CD138-
enriched and –depleted samples (n = 3), following four days of culture in complete RPMI 
supplemented with CD40L+IL-4+IL-5. Relative gene expression was analyzed using the 
2-ΔΔCT method, and normalized to Tbp expression. Fold change in expression relative to 
WT CD138- cells is shown as mean ± SEM. * p < 0.05, ** p < 0.01, as per Kruskal-Wallis 
test, with Dunn’s multiple comparisons test. 
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Differentiation of enriched B cells into CD138+ cells was likewise correlated with a 
significant downregulation of Bcl6 mRNA in both Spib-/- and Spib-/-Spic+/- subsets, but not 
in WT CD138+ samples (Fig. 3-7D). IRF4 mRNA transcript levels followed pattern of 
expression reminiscent of Prdm1, which was expected based on the documented regulation 
of Prdm1 by IRF4 (Sciammas et al., 2006). IRF4 mRNA levels were significantly 
increased in WT, Spib-/- and Spib-/-Spic+/-  CD138+ samples (Fig. 3-7E). The above results 
indicate that loss of Spi-B or Spi-C on a Spib-deficient background alters the transcriptional 
landscape which directs the maintenance of B cell, GC B cell and PC identities, promoting 
gene expression patterns which support plasma cell differentiation. 
3.5 Analysis of PU.1, Spi-B and Spi-C binding within the Bach2 
locus 
The observed downregulation of Bach2 in CD138-expressing Spib-/-, but not in Spib-/-
Spic+/- or WT subsets, rendered the gene an attractive candidate for opposing transcriptional 
regulation by Spi-B and Spi-C. We sought further evidence for the potential regulation of 
Bach2 by Spi-B and or Spi-C. We observed a reduction in the relative levels of Bach2 
transcripts in B cells enriched from the spleens of Spib-/-Spic+/- animals, relative to that 
found in WT samples (Fig. 3-8A). Re-analysis of RNA-seq data sets from sorted FO B 
cells, GC B cells, PBs and PCs (Shi et al., 2015) additionally revealed that Spi-B and Bach2 
exhibit similar expression patterns during B cell terminal differentiation (Fig. 3-8B,C). 
While Spib and Bach2 expression remains high in the GC compartment, their expression 
is substantially downregulated following commitment to the PC fate (Fig. 3-8B,C). By 
contrast, Spi-C expression is seemingly repressed in GC B cells, and experiences 
progressive upregulation through the PB and terminal PC stages (Fig. 3-8D). The inversely 
correlated expression patterns of Spi-B and Spi-C in these cellular subsets lends support to 
their displaying opposing roles in B cell terminal differentiation.  
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Figure 3-8. Spi-B and Bach2 expression patterns during B cell terminal 
differentiation are highly concordant. (A) RT-qPCR analysis of Bach2 expression in 
splenic enriched B cells from the indicated genotypes (n = 4). Relative gene expression 
was analyzed using the 2-ΔΔCT method, and normalized to Tbp expression. Fold change in 
expression relative to WT enriched B cells is shown as mean ± SEM. * p < 0.05 as per 
Friedman test, with Dunn’s multiple comparison test. (B-D) Re-analysis of RNA-seq data 
sets from (Shi et al., 2015), depicting the normalized expression of Spi-B (B), Bach2 (C) 
and Spi-C (D) in sorted FO B cells (n = 2), GC B cells (n = 2), plasmablasts (PBs, n = 1) 
and splenic PCs (n = 3). Bars represent mean Log2FKPM values ± SEM. 
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To determine whether evidence of Spi-B or PU.1 binding could be observed within the 
Bach2 gene locus, previously published anti-FLAG chromatin immunoprecipitation and 
next-generation sequencing (ChIP-seq) of WEHI-279 lymphoma cells, transduced with 
3XFLAG-tagged PU.1 and Spi-B, was re-analyzed for the purpose of our study (Solomon 
et al., 2015). Though a number of PU.1 and Spi-B interaction sites were identified 
throughout intronic regions of the Bach2 locus, few sites of PU.1 and Spi-B enrichment 
was found to be located within 15 kb of the transcription start site (Fig. 3-9B).  
Four peaks were arbitrarily defined as regions-of-interest (ROI) for potential regulation of 
Bach2 expression based on enrichment of PU.1 and Spi-B binding (Fig. 3-9B). We 
additionally examined Spi-C enrichment within the defined ROIs, using ChIP-seq 
performed in MIG-3XFLAG-SpiC-transduced 38B9 pro-B cells. We observed a moderate 
peak of Spi-C binding within ROI 1, but not in ROIs 2-4 (Fig. 3-9B). Multi-species 
conservation analysis (PhastCons46wayPlacental) of ROIs was performed using the 
publically available ORCA toolkit, and revealed a high degree of conservation in ROIs 1 
and 3, found in Bach2 introns 1 and 2, respectively (Fig. 3-9C). The MEME Suite, which 
was used to confirm the presence of GGAA motifs within ROIs, identified GAGG/AAA 
as the top enriched motif (data not shown). 
To examine whether Spi-B and Spi-C bound ROIs in stimulated B cells, enriched WT B 
cells were stimulated overnight in IL-4, IL-5 and CD40L, then transduced using retrovirus 
carrying MIG-3XFLAG-SpiB, MIG-3XFLAG-SpiC or with an empty MIGR1 vectors 
(Fig. 3-9D). Chromatin from transduced and stimulated B cells was immunoprecipitated 
using anti-FLAG antibodies, and used as input for qPCR targeting highly conserved ROIs 
1 and 3, and on a negative control region (NCR) selected from intron 2 of Bach2 (Fig. 3-
9B). Mean transduction efficiency, as determined by percentage of GFP+ cells, ranged from 
55.80% (SD: 3.205) in MIGR1-transduced cells, to 16.30% (SD: 3.724) and 14.87% (SD: 
4.829) in MIG-3XFLAG-SpiB and SpiC-infected cells, respectively (Fig. 3-9E). Percent 
input analysis revealed significant enrichment of Spi-C at ROI 1 and 3, relative to the NCR 
and compared to that of MIGR1-transduced cells (Fig. 3-9F-H). Spi-C binding at ROI 3 
suggests a specific interaction of Spi-C and the Bach2 gene locus in activated B cells, as 
no such enrichment was predicted from the ChIP-seq data in 38B9 cells. Direct Spi-B 
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binding was likewise observed at ROI 3, compared to basal MIGR1 and NCR enrichment 
(Fig. 3-9F,H). Together, our data indicates that Spi-B and Spi-C are capable of binding 
intronic regions of Bach2 directly, and may be involved in the regulation of Bach2 
expression in stimulated B cells.  
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Figure 3-9. Potential regulation of Bach2 expression by SPI subfamily transcription 
factors PU.1, Spi-B and Spi-C. (A) RT-qPCR analysis of Bach2 expression in splenic 
enriched B cells from the indicated genotypes (n = 4). Relative gene expression 
was normalized to Tbp expression. Fold change in expression relative to WT enriched B 
cells is shown as mean ± SEM. * p < 0.05 as per Friedman test, with Dunn’s multiple 
comparison test. (B) UCSC genome browser tracks of ChIP-seq analysis of 3XFLAG-
tagged PU.1 and Spi-B in WEHI-279 lymphoma cells, along with 3XFLAG-tagged Spi-C 
in 38B9 pre-B cell line. Two common Bach2 isoforms are shown below, with black boxes 
denoting exons and lines representing introns. Red boxes indicate regions-of-interest 
(ROIs), while the blue box denotes the negative control region (NCR). (C) Multiple 
placental species conservation analysis (in red) the visualized as superimposed USCS 
tracks of ROIs (peaks 1-4, in black) within the Bach2 locus for PU.1 and Spi-B. (D) 
Schematic depicting the workflow for primary B cell transduction, followed by chromatin 
immunoprecipitation (ChIP). (E) Frequency of GFP+ cells, 48 hours following transduction 
of WT enriched B cells with the indicated retroviral vectors. Bars represent the mean 
transduction efficiency (n = 3) ± SEM. (F-H) Enrichment of FLAG-tagged Spi-B and Spi-
C in stimulated WT B cells at the NCR (F), ROI 1 (G) and ROI 3 (H). Results are shown 
as percentage of input DNA, with bars representing mean % input ± SEM from three 
independent experiments. * p < 0.05, ** p < 0.01 as per one-way ANOVA, performed with 
Tukey’s multiple comparisons test.  
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4 Chapter 4: Discussion 
4.1 General Discussion 
The mouse B cell lineage lends itself as a relevant model to the study of cell fate 
determination throughout immune responses. The distinct B lymphocyte populations 
which arise from mature precursors, following a T cell-dependent immunogenic challenge, 
are relatively well known, having been the focus of extensive characterization efforts (De 
Silva & Klein, 2015a; Nutt et al., 2015). Analysis of these various subsets—utilizing 
characteristics such as cell-surface markers, Ig isotype, mutational burden, etc.—allows for 
gain of insight into the robustness and quality of humoral immune responses. While the 
characteristics of antibody-forming effectors have largely been established, the manner in 
which activated B cells undergo fate decisions between the plasmacytic and memory fates 
remains elusive. 
The purpose of the present study was to explore the role of Spi-C in antibody-forming 
responses and activated B cell fate decisions. Herein, we showed that Spi-C heterozygosity 
on a Spib-/- background rescues the reductions in ASC frequencies observed in Spib-/- mice, 
following prime-boost immunization with model antigen NP-OVA. Preliminary evidence 
suggests that Spib-/- secondary GC formation may be impaired, 7 days following a 
secondary immunogenic challenge. Through ex vivo T cell-dependent-type stimulation of 
spleen-derived enriched B cells, we revealed an increased tendency for both Spib-/- and 
Spib-/-Spic+/- B cells to differentiate into CD138-expressing ASCs, relative to WT cells. 
Whereas stimulated Spib-/- B cells underwent accelerated differentiation at earlier cell 
divisions, Spib-/-Spic+/- B cells exhibited an intermediate phenotype, compared to the WT. 
Gene expression analysis performed using Spib-/- and Spib-/-Spic+/- CD138+ B cells 
indicates that loss of Spi-B and Spi-C alters the expression of genes which influence 
activated B cell fate decisions. In the case of Spi-B deletion, these changes are conducive 
to differentiation into the PC fate. Bach2 was identified as a candidate gene for putative 
regulation by Spi-B and Spi-C. By ChIP-PCR, we showed that Spi-B and Spi-C bind 
directly to intronic regions of the Bach2 locus. Together, our results suggest that Spi-C is 
involved in shaping antibody-forming responses, by influencing the differentiation of 
activated B cells in opposition to Spi-B. 
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PU.1 and Spi-B exhibit a large degree of functional redundancy in the B cell lineage (Ray-
Gallet, Mao, Tavitian, & Moreau-Gachelin, 1995; Solomon et al., 2015). Germline ablation 
of PU.1 in mice has long been known to generate nonviable offspring, which lack both 
myeloid and lymphoid lineages (McKercher et al., 1996; Scott et al., 1994). By contrast, 
Spib-/- mice are capable of producing mature B cells, though these cells exhibit marked 
proliferation defects in response to BCR stimulation (Garrett-Sinha et al., 1999; Li et al., 
2015; Su et al., 1997). We have previously shown that spleens from Spib-/- animals contain 
reduced numbers of mature follicular (FO) B cells and transitional type 2 (T2) B cells (Li 
et al., 2015). Spi-B deficiency has previously been documented to bear functional 
significance during B cell antibody-forming responses in vivo (Su et al., 1997). While titers 
of class-switched antibodies appear normal during T cell-dependent primary responses, 
Spib-/- mice display an impaired ability to generate secondary titers of IgG1, IgG2a and IgG2b 
isotypes (Su et al., 1997). Our work corroborates a deficiency of Spib-/- mice during 
secondary challenges to the T cell-dependent antigen NP, despite a lack of observable 
defects during primary responses, in relation to that of WT mice. This defect was 
specifically observed in frequencies of IgG1-producing ASCs, which secrete the dominant 
class-switched isotype generated in responses to NP-OVA immunization (Xu et al., 2015). 
The use of ELISpot assays enabled the analysis of responding cell frequencies, as opposed 
to circulating antibody titers. While we cannot rule out a putative reduction in the quantity 
of antibodies produced on a per cell basis, it is likely that these secondary antibody-forming 
defects arise primarily due to a decrease in the splenic frequencies of ASCs in Spib-/- 
animals. The capacity for Spi-C heterozygosity to rescue this apparent memory defect 
highlights a novel role for this factor in regulating Ab-forming responses. 
The mounting of humoral immune responses is a highly complex and dynamic process, 
involving the coordinated activation of numerous cell types—including DCs and antigen-
specific T cells and B cells (Parham, 2015). The observed impairments during Spib-/- recall 
responses could thus be owed to a number of discrete, B cell-intrinsic or extrinsic defects. 
One potential explanation is that Spib-/- mice present with defects in the MBC compartment, 
which may account for impaired antibody-forming responses upon secondary antigenic 
challenge. More specifically, Spib-/- mice could exhibit reduced frequencies of MBCs, or 
functionally defective MBCs of similar abundance than those found in WT mice. 
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Reductions in MBC frequencies could feasibly contribute to impaired recall responses in 
Spib-/- mice by hampering the formation of secondary GCs (Wang et al., 2017). Our 
preliminary flow cytometric analyses of GCs at 37 d.p.i. seem to support the notion that 
Spib-/- mice exhibit defective secondary GCs. Interestingly, GC B cell frequencies may be 
rescued in Spib-/-Spic+/- spleens. We considered the possibility that impaired recall 
responses in Spib-/- mice might be the result of short-lived, or otherwise faulty memory T-
B interactions, as genetic ablation of Spi-B in T cells might generate T cell-intrinsic defects 
(Su et al., 1996). While we are currently unable to rule out memory T cell defects, we 
showed that enriched Spib-/- B cells, stimulated ex vivo in the presence of excess T cell-
derived signals, such as CD40L, IL-4 and IL-5, exhibit an intrinsic propensity towards ASC 
differentiation. These results, considered alongside in vivo evidence of a memory defect, 
have led us to hypothesize that loss of Spi-B promotes ASC differentiation at the expense 
of MBC differentiation. Correspondingly, loss of Spi-C might de-repress MBC 
differentiation, and alleviate the impairment in recall responses observed in Spib-/- mice. 
Under the most prevalent paradigm, activated B cells are thought to undergo a bifurcation 
in developmental outcomes, wherein a subset of GC B cells differentiates into ASCs, and 
another, into MBCs (Xu et al., 2015). Our present work, along with that of others, indicates 
that loss of Spi-B predisposes B cells to differentiate into PCs (Schmidlin et al., 2008; 
Willis et al., 2017). Despite similar frequencies of CD138+ ASCs having been generated 
by both Spib-/- and Spib-/-Spic+/- cultures following stimulation, we observed a modest lag 
in the frequencies of Spib-/-Spic+/- CD138+ ASCs in early rounds of CTV-labelled cell 
divisions. This delay suggests that loss of Spi-C decelerates PC differentiation in Spi-B-
deficient B cells, and that Spi-C may thus act as a pro-plasmacyte fate transcription factor 
in activated B cells. Gene expression analysis of stimulated WT, Spib-/- and Spib-/-Spic+/- B 
cells further supports an intrinsic bias of Spib-/- towards ASC differentiation, which is at 
least partially countered by concurrent loss of one allele of Spi-C.  
Putative functional impairments in the Spib-/- MBC compartment could stem from intrinsic 
or extrinsic MBC defects. Intrinsic defects, such as an altered treshold of re-activation, or 
failure to obtain sufficient help from primed T cells might underlie the observed defects in 
Spib-/- recall responses (Ochsenbein et al., 2000). By contrast, MBC extrinsic activation 
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requirements have been suggested to include the proper homing of MBCs to specific 
lymphoid compartments (Elgueta et al., 2015; Hebeis et al., 2004). To our knowledge, 
studies investigating the requirements for MBC reactivation, in the context of antigen re-
exposure, are scarce. One such study, however, outlines the critical role of BCR signalling, 
via the Ig tail tyrosine motif, in MBC maintenance and re-activation (Lutz et al., 2015). 
BCR signalling was shown to enhance the ability of IgG-switched MBCs to reactivate and 
differentiate into ASCs, in the absence of T cell help (Lutz et al., 2015). The importance of 
both tonic and episodic BCR signal transduction in MBC function is highly relevant to the 
antibody-forming defects demonstrated in Spib-/- mice during secondary antigenic 
challenge. Spi-B is known to coordinate the induction of genes involved in BCR signaling, 
such as Blnk, Syk and Grap2 (Bednarski et al., 2016; Garrett-Sinha et al., 2005; Xu et al., 
2012). Correspondingly, our group has previously shown that Spi-B-deficient B cells 
demonstrate proliferation defect following stimulation with anti-IgM antibodies, and that 
heterozygous loss of Spi-C rescues this phenotype (Li et al., 2015). We speculate that BCR 
signaling defects in Spib-/- MBCs hamper the ability of these cells to reactivate, which 
manifests in impaired recall responses to T cell-dependent antigens. The observed rescue 
of secondary IgG1 responses in Spib-/-Spic+/- mice might correspondingly be expected to 
originate from de-repression of BCR signaling target genes regulated by Spi-C—namely 
of Btk, Blnk and Syk (Bednarski et al., 2016; Zhu et al., 2008). 
The work presented herein is, to the best of our knowledge, the first report of a potential 
defect in the early primary responses of Spib-/- mice to haptenated antigens. The ‘non-
responder’ phenotype, which presented as a complete lack of class-switched ASCs in a 
subset of NP-OVA-immunized Spib-/- mice, has not been observed as part of other studies 
investigating T cell-dependent responses in these mice (Su et al., 1997; Willis et al., 2017). 
DNP-specific IgM and IgG1 antibody titres remained unchanged in Spib-/- and Spib+/- mice 
relative toWT controls, when assayed at days 5 and 8 post-immunization with DNP-KLH 
(Su et al., 1997). In concordance with both our work and that of Su et al., Willis and 
colleagues reported normal frequencies of NP-specific, IgG1-switched ASCs by ELISpot 
analysis conducted 14 days post-immunization (Su et al., 1997; Willis et al., 2017). Both 
of the previous works outlined make no mention of a non-responder phenotype. Given the 
apparent defect that we and others have identified in Spib-/- secondary responses, the 
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possibility of faulty primary immunizations requires careful consideration. In our view, 
this potential explanation is limited by the lack of non-responders in control mice, and by 
the immune profile of Spib-/- mice following a secondary immunogenic challenge. Despite 
their reduced frequencies of IgG1-producing ASCs at day 37 post-immunization, Spib-/- 
mice still exhibit IgG1-dominated responses–patterns of class-switching which are 
inconsistent that of primary responses. To confirm the existence of the non-responder 
phenotype, Spib-/- mice could be immunized with a panel of additional T cell-dependent 
immunogens, such as haptenated KLH, chicken γ globulin (CGG) or sheep red blood cells 
(SRBC), and their spleens analyzed by flow cytometry using 4-hydroxy-3-iodo-5-
nitrophenylacetate (NIP)-conjugated reagents, in order to identify hapten-specific 
responding cells (Tomayko, Steinel, Anderson, & Shlomchik, 2010). 
Impairments in GC reactions stand as another potential explanation for the observed 
reductions responding B cell frequencies of Spib-/- mice. The internal complexity of GCs 
likely renders these structures sensitive to subtle alterations in gene expression. We 
speculate that loss of Spi-B could contribute to possible impairments in initial 
establishment, maintenance, GC B cell selection and recirculation—processes which may 
ultimately affect GC output (De Silva & Klein, 2015b). Evidence of GCs defects have 
previously been reported in Spib-/- mice (Su et al., 1997; Willis et al., 2017). Early reports 
showed that primary Spib-/- GCs are small and poorly sustained at day 28 post-
immunization, relative to WT mice (Su et al., 1997). The premature collapse of Spib-/- was 
largely attributed to increased apoptosis of GC B cells in the absence of Spi-B (Su et al., 
1997). Sfp1+/-Spib-/- mice, which lack Spi-B and harbour one functional PU.1 allele, fail to 
generate splenic GCs following immunization (Garrett-Sinha et al., 1999). These reports 
support the notion that PU.1 and Spi-B jointly contribute to both GC formation and 
maintenance. By contrast, the role of Spi-C with regards to GC establishment and 
maintenance is currently unknown. The potential rescue of GC B cell frequencies in 
secondary Spib-/-Spic+/- GCs may contribute to restored frequencies IgG1-ASC frequencies 
observed at 37 d.pi. Our results prompt us to speculate that Spi-C may be involved in 
negatively regulating GC reactions, by exerting transcriptional repression over Bach2. 
Further, and despite the involvement of BCR signaling in GC B cell selection remaining 
controversial, we speculate that impaired BCR signaling in Spib-/- GC B cells might be 
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linked to increased intra-GC apoptosis or aberrant affinity-based B cell selection into the 
PC or MBC compartments (Su et al., 1997). Sequencing and mutation analysis of variable 
heavy Ig regions from sorted GC B may provide insight into the affinity profile of Spi-B 
and Spi-C deficient mice (Preite et al., 2015). Further microscopy experiments with Eµ-
Spi-C+ mice will be required to visualize the importance of Spi-C regulation in both 
primary and secondary GCs. 
The ChIP-PCR analysis conducted as part of our study has identified putative regulatory 
regions within the Bach2 locus, which were bound by Spi-B and Spi-C. Our report is not 
without precedent, however, as transcriptional cross-talk between Ets family members and 
the BTB Domain and CNC Homologue (Bach) factors has previously been documented. 
Within the monocyte lineage, Bach1 directs the transcriptional repression of Spi-C in the 
absence of heme (Haldar et al., 2014; Kohyama et al., 2009). Heme-induced degradation 
of Bach1 results in the upregulation of Spi-C, which itself mediates the differentiation of 
monocytes into heme-scavenging red pulp macrophages (Haldar et al., 2014; Kohyama et 
al., 2009). The closely-related, B cell-restricted factor Bach2 presents as an interesting 
potential regulatory element in the context of activated B cell fate decisions. Induction of 
Bach2 in GC B cells is known to inhibit PC differentiation, owing in part to its ability to 
directly repress Blimp-1 (Huang, Geng, Boss, Wang, & Melnick, 2014; Ochiai et al., 2008). 
High levels of Bach2 promote commitment of low-affinity activated B cells to the memory 
B cell fate in a Blimp-1-independent manner, while repression of Bach2 in IgG1 MBCs 
favours plasma cell generation (Kometani et al., 2013; Shinnakasu et al., 2016). Bach2-/- 
mice exhibit, upon TD immunization, impairments in GC formation and CSR (Muto et al., 
2004). In this study, we have shown that levels of Bach2 mRNA are decreased in Spib-/-
Spic+/- enriched splenic B cells, relative to that of WT mice. Upon stimulation in Th2-like 
conditions, differentiated Spib-/- cells, but not CD138+ Spib-/-Spic+/- or WT cells, exhibit 
reduced levels of Bach2 transcripts compared to non-differentiated WT cells. More 
specifically, Spi-B and Spi-C enrichment was demonstrated at two intronic sites of Bach2, 
suggesting their potential role as transcriptional regulators of Bach2 expression in activated 
B cells. While some evidence indicates that human Spi-B directly represses Prdm1 
(Schmidlin et al., 2008), our data suggests that Spi-B may indirectly exert regulation over 
Blimp-1 expression via induction of Bach2. Establishing the role of Spi-C with regards to 
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Bach2 expression requires further analysis, due to Spi-C’s documented ability to function 
as either an activator or repressor of transcription in B cells (Carlsson et al., 2003; DeKoter 
et al., 2010; Li et al., 2015; Schweitzer et al., 2006; Zhu et al., 2008). 
The long-term aim of our work is to understand the regulatory contributions of Ets-family 
transcription factors PU.1, Spi-B and Spi-C in guiding B cell development and enabling 
mature B cell functioning. The governing hypothesis driving our investigation was that 
Spi-C opposes the regulatory function of Spi-B in B cell antibody-forming responses. The 
results presented herein were shown to support our hypothesis, as loss of Spi-C restored 
the reduced frequencies of antibody-forming cells generated by Spib-/- mice. Taken 
together, our study highlights a previously uncharacterized role for the Ets-family 
transcription factor Spi-C in regulating ASC differentiation, along with antibody-forming 
responses to both primary and secondary antigenic challenge. Further analysis is required 
to identify the specific function of Spi-C on the transcription of its target genes in the 
context of activated B cell fate decisions, as well as its impact on GC reactions. 
Understanding the molecular circuitry which governs B cell fate decisions during immune 
responses may ultimately bear important implications for the design of vaccination 
strategies, which aim to provide high levels of protective antibody titers over long periods 
of time. 
4.2 Future Directions 
The work conducted as part of this thesis has identified a novel role for Spi-C in regulating 
antibody-forming responses during T cell-dependent responses, along with a potential 
mechanism for the respective positive and negative regulation exerted by Spi-C and Spi-B 
on terminal B cell differentiation. Despite direct binding of Spi-B and Spi-C having been 
shown to occur at intronic regions of Bach2 at the activated B cell stage, the specific 
regulatory function of these factors at identified target sites remains to be established. 
Previous work from our laboratory has led to the hypothesis that Spi-B and Spi-C act as 
mutually antagonistic factors in the regulation of Nfkb1 in B cells primarily through their 
competition of occupancy at shared regulatory binding sites (Li et al., 2015). This 
hypothesis remains pertinent in view of the putative regulation of Bach2 by the 
transcription factors Spi-B and Spi-C.  
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The impairment in recall responses exhibited by Spib-/- mice, along with their apparent 
rescue in Spib-/-Spic+/- littermates prompts an investigation into GC and memory formation. 
To first characterize the GC phenotype of Spib-/-Spic+/- mice, we propose to perform 
immunofluorescence microscopy experiments to examine splenic GCs at 10, 28 and 37 
d.p.i. While the first two timepoints would provide information regarding primary GCs and 
their maintenance, the 37 d.p.i timepoint would enable us to visualize secondary GCs. A 
tricolor panel for IgD, PNA or GL-7 and anti-CD35 would be utilized to quantitatively 
compare GC size, and % of GC-positive follicles within splenic sections of Spib-/-Spic+/-, 
Spib-/- and WT mice. IgD staining is generally used to identify B cell follicles, which are 
primarily colonized by naïve IgD+ B cells. PNA and GL-7 have classically been used to 
stain GC B cells of the DZ, while CD35 identifies follicular dendritic cells in the LZ (Imai 
& Yamakawa, 1996).  
To investigate potential defects in the Spib-/- memory compartment, we propose to conduct 
an in vivo functional assay. We will first immunize Spib-/-, Spib-/-Spic+/- and WT with 
haptenated ovalbumin at two separate time points, one week apart, to allow for the robust 
generation of memory. Following the second immunogenic challenge, the mice will be 
rested for at least five weeks. At this 7 week time point, the mice will be sacrificed, and 
their spleens harvested. B cells will be enriched from splenocytes using the Miltenyi 
system, and transferred intravenously into immunodeficient Rag1 knockout recipient mice, 
as described in (Lutz et al., 2015). Following a third challenge with NP-KLH, flow 
cytometry will be performed on the spleens of recipient mice to detect frequencies of 
CD138+ ASCs—which would have arisen primarily through the reactivation of previously 
generated MBCs. We hypothesize that Rag1 knockout mice which received cells obtained 
from Spib-/- mice will exhibit impaired antibody-forming responses, while recipients 
having received Spib-/-Spic+/- and WT enriched B cells will fare comparably well. The 
experimental protocol outlined above could be modified to examine NP-specific antibody 
titres in recipient mice, or be used to sort MBCs from our genotypes of interest to perform 
ex vivo assays such as ELISpots. The goal of these experiments would be to establish a role 
for Spi-B and Spi-C in memory formation. 
Transcriptional regulation of terminal B cell differentiation and antibody-forming 
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responses by SPI subfamily members in relation to the heme-binding Bach factors merits 
further investigation. While our work puts forth the idea that Spi-B and Spi-C might oppose 
each other for transcriptional control of the Bach2 locus, countervailing regulation by 
Bach2 over the Ets factors must also be considered. It is conceivable that Bach2 could be 
involved in the transcriptional regulation of Spi-C, as the closely-related factor Bach1 has 
previously been shown to repress Spi-C expression in monocytes (Haldar et al., 2014). 
Interestingly, the addition of heme to LPS-stimulated B cell cultures has previously been 
shown to promote PC differentiation in a Bach2-dependent fashion (Watanabe-Matsui et 
al., 2011). These results raise the possibility that an abundance of heme could mediate 
increased PC differentiation by inducing Spi-C expression. We hypothesize that Bach2 and 
Spi-C comprise a feed-forward, negative regulatory loop in activated B cells, which is 
initiated at the GC stage (Fig. 4-1). Bach2 expression is elevated in GC B cells, possibly 
serving to maintain repression at the Spi-C locus. During terminal differentiation, Bach2 
is downregulated, potentially allowing for the de-repression of the Prdm1 and Spic loci. 
Elevated expression of Spi-C in PBs would eventually support repression at the Bach2 
locus throughout their entering the PC stage. Overall, the putative net impact of Spi-C 
upregulation would be to support PC differentiation via repression of Bach2. 
To explore the possibility of heme-mediated transcriptional regulation of Spi-C during 
antibody-forming responses, several experiments can be proposed. The observation that 
heme induces PC differentiation in LPS-stimulated B cells would first need to be validated 
using our own ex vivo T cell-dependent-type stimulation assay—using flow cytometry to 
determine frequencies of CD138-expressing cells.  
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Figure 4-1. Schematic for the potential feed-forward negative regulatory loop of Spi-
C and Bach2 expression. In GC B cells, expression of Bach2 is high, which maintains 
repression at the Spi-C locus. During a plasmacytic differentiation event, Bach2 is 
downregulated, allowing for the de-repression of Blimp-1 and Spi-C. Elevated expression 
of Spi-C in plasma cells eventually helps to maintain repression at the Bach2 locus. High 
concentrations of heme, or heme metabolites, have been demonstrated to induce Spi-C 
expression in monocytes, which suggests a potential role for heme-mediated regulation of 
plasma cell differentiation. 
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If our hypothesis is correct, exposure to heme would result in a more dramatic increase in 
Spi-C expression during PC differentiation. Evidence of Bach2 enrichment near the Spic 
locus could be obtained by re-analysis of available Bach2 ChIP, and might instruct future 
chromatin conformation capture (3C) assays in identifying potential distal enhancers of 
Spic (Hagège et al., 2007). Moreover, it is known that certain human hematopoietic 
disorders, such as β-thalassemia major, involve the release of abundant quantities of heme 
into circulation upon widespread hemolysis (Garcia dos Santos et al., 2015). Human blood 
or spleen samples, obtained by splenectomies performed to mitigate the condition, may be 
useful in determining whether abundant quantities of heme can alter the immune profile of 
individuals, by promoting PC differentiation. Ultimately, these studies would seek to 
generate greater insight into the roles of Ets factors Spi-B and Spi-C during B cell 
responses, and identify potential translational research opportunities to study these factors 
in the context of human disease. 
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